Motif 787 (n=97)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A6NKT7 | RGPD3 | S978 | ochoa | RanBP2-like and GRIP domain-containing protein 3 | None |
O00139 | KIF2A | S586 | ochoa | Kinesin-like protein KIF2A (Kinesin-2) (hK2) | Plus end-directed microtubule-dependent motor required for normal brain development. May regulate microtubule dynamics during axonal growth. Required for normal progression through mitosis. Required for normal congress of chromosomes at the metaphase plate. Required for normal spindle dynamics during mitosis. Promotes spindle turnover. Implicated in formation of bipolar mitotic spindles. Has microtubule depolymerization activity. {ECO:0000269|PubMed:15843429, ECO:0000269|PubMed:17538014, ECO:0000269|PubMed:18411309, ECO:0000269|PubMed:30785839}. |
O14715 | RGPD8 | S977 | ochoa | RANBP2-like and GRIP domain-containing protein 8 (Ran-binding protein 2-like 3) (RanBP2-like 3) (RanBP2L3) | None |
O43166 | SIPA1L1 | S1181 | ochoa | Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1) | Stimulates the GTPase activity of RAP2A. Promotes reorganization of the actin cytoskeleton and recruits DLG4 to F-actin. Contributes to the regulation of dendritic spine morphogenesis (By similarity). {ECO:0000250}. |
O43439 | CBFA2T2 | S551 | ochoa | Protein CBFA2T2 (ETO homologous on chromosome 20) (MTG8-like protein) (MTG8-related protein 1) (Myeloid translocation-related protein 1) (p85) | Transcriptional corepressor which facilitates transcriptional repression via its association with DNA-binding transcription factors and recruitment of other corepressors and histone-modifying enzymes (PubMed:12559562, PubMed:15203199). Via association with PRDM14 is involved in regulation of embryonic stem cell (ESC) pluripotency (PubMed:27281218). Involved in primordial germ cell (PCG) formation. Stabilizes PRDM14 and OCT4 on chromatin in a homooligomerization-dependent manner (By similarity). Can repress the expression of MMP7 in a ZBTB33-dependent manner (PubMed:23251453). May function as a complex with the chimeric protein RUNX1/AML1-CBFA2T1/MTG8 (AML1-MTG8/ETO fusion protein) which is produced in acute myeloid leukemia with the chromosomal translocation t(8;21). May thus be involved in the repression of AML1-dependent transcription and the induction of G-CSF/CSF3-dependent cell growth. May be a tumor suppressor gene candidate involved in myeloid tumors with the deletion of the 20q11 region. Through heteromerization with CBFA2T3/MTG16 may be involved in regulation of the proliferation and the differentiation of erythroid progenitors by repressing the expression of TAL1 target genes (By similarity). Required for the maintenance of the secretory cell lineage in the small intestine. Can inhibit Notch signaling probably by association with RBPJ and may be involved in GFI1-mediated Paneth cell differentiation (By similarity). {ECO:0000250|UniProtKB:O70374, ECO:0000269|PubMed:23251453, ECO:0000303|PubMed:12559562, ECO:0000303|PubMed:15203199}. |
O60763 | USO1 | S717 | ochoa | General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein) | General vesicular transport factor required for intercisternal transport in the Golgi stack; it is required for transcytotic fusion and/or subsequent binding of the vesicles to the target membrane. May well act as a vesicular anchor by interacting with the target membrane and holding the vesicular and target membranes in proximity. {ECO:0000250|UniProtKB:P41542}. |
O75427 | LRCH4 | S281 | ochoa | Leucine-rich repeat and calponin homology domain-containing protein 4 (Leucine-rich repeat neuronal protein 4) (Leucine-rich neuronal protein) | Accessory protein that regulates signaling by multiple TLRs, acting as a broad-spanning regulator of the innate immune response. In macrophages, binds LPS and promotes proper docking of LPS in lipid raft membrane. May be required for lipid raft maintenance. {ECO:0000250|UniProtKB:Q921G6}. |
O75694 | NUP155 | S1057 | ochoa | Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155) | Essential component of nuclear pore complex. Could be essessential for embryogenesis. Nucleoporins may be involved both in binding and translocating proteins during nucleocytoplasmic transport. {ECO:0000250|UniProtKB:Q99P88}. |
P07237 | P4HB | Y99 | ochoa | Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55) | This multifunctional protein catalyzes the formation, breakage and rearrangement of disulfide bonds. At the cell surface, seems to act as a reductase that cleaves disulfide bonds of proteins attached to the cell. May therefore cause structural modifications of exofacial proteins. Inside the cell, seems to form/rearrange disulfide bonds of nascent proteins. At high concentrations and following phosphorylation by FAM20C, functions as a chaperone that inhibits aggregation of misfolded proteins (PubMed:32149426). At low concentrations, facilitates aggregation (anti-chaperone activity). May be involved with other chaperones in the structural modification of the TG precursor in hormone biogenesis. Also acts as a structural subunit of various enzymes such as prolyl 4-hydroxylase and microsomal triacylglycerol transfer protein MTTP. Receptor for LGALS9; the interaction retains P4HB at the cell surface of Th2 T helper cells, increasing disulfide reductase activity at the plasma membrane, altering the plasma membrane redox state and enhancing cell migration (PubMed:21670307). {ECO:0000269|PubMed:10636893, ECO:0000269|PubMed:12485997, ECO:0000269|PubMed:21670307, ECO:0000269|PubMed:32149426}. |
P0DJD0 | RGPD1 | S962 | ochoa | RANBP2-like and GRIP domain-containing protein 1 (Ran-binding protein 2-like 6) (RanBP2-like 6) (RanBP2L6) | None |
P0DJD1 | RGPD2 | S970 | ochoa | RANBP2-like and GRIP domain-containing protein 2 (Ran-binding protein 2-like 2) (RanBP2-like 2) (RanBP2L2) | None |
P0DMV8 | HSPA1A | S340 | ochoa | Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 1) (HSP70-1) (HSP70.1) (Heat shock protein family A member 1A) | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The co-chaperones have been shown to not only regulate different steps of the ATPase cycle, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The co-chaperones are of three types: J-domain co-chaperones such as HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24012426, PubMed:24318877, PubMed:26865365). Maintains protein homeostasis during cellular stress through two opposing mechanisms: protein refolding and degradation. Its acetylation/deacetylation state determines whether it functions in protein refolding or protein degradation by controlling the competitive binding of co-chaperones HOPX and STUB1. During the early stress response, the acetylated form binds to HOPX which assists in chaperone-mediated protein refolding, thereafter, it is deacetylated and binds to ubiquitin ligase STUB1 that promotes ubiquitin-mediated protein degradation (PubMed:27708256). Regulates centrosome integrity during mitosis, and is required for the maintenance of a functional mitotic centrosome that supports the assembly of a bipolar mitotic spindle (PubMed:27137183). Enhances STUB1-mediated SMAD3 ubiquitination and degradation and facilitates STUB1-mediated inhibition of TGF-beta signaling (PubMed:24613385). Essential for STUB1-mediated ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg) during inflammation (PubMed:23973223). Required as a co-chaperone for optimal STUB1/CHIP ubiquitination of NFATC3 (By similarity). Negatively regulates heat shock-induced HSF1 transcriptional activity during the attenuation and recovery phase period of the heat shock response (PubMed:9499401). Involved in the clearance of misfolded PRDM1/Blimp-1 proteins. Sequesters them in the cytoplasm and promotes their association with SYNV1/HRD1, leading to proteasomal degradation (PubMed:28842558). {ECO:0000250|UniProtKB:P0DMW0, ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256, ECO:0000269|PubMed:28842558, ECO:0000269|PubMed:9499401, ECO:0000303|PubMed:24012426, ECO:0000303|PubMed:26865365}.; FUNCTION: (Microbial infection) In case of rotavirus A infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. {ECO:0000269|PubMed:16537599}. |
P0DMV9 | HSPA1B | S340 | ochoa | Heat shock 70 kDa protein 1B (Heat shock 70 kDa protein 2) (HSP70-2) (HSP70.2) (Heat shock protein family A member 1B) | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The co-chaperones have been shown to not only regulate different steps of the ATPase cycle, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The co-chaperones are of three types: J-domain co-chaperones such as HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24012426, PubMed:24318877, PubMed:26865365). Maintains protein homeostasis during cellular stress through two opposing mechanisms: protein refolding and degradation. Its acetylation/deacetylation state determines whether it functions in protein refolding or protein degradation by controlling the competitive binding of co-chaperones HOPX and STUB1. During the early stress response, the acetylated form binds to HOPX which assists in chaperone-mediated protein refolding, thereafter, it is deacetylated and binds to ubiquitin ligase STUB1 that promotes ubiquitin-mediated protein degradation (PubMed:27708256). Regulates centrosome integrity during mitosis, and is required for the maintenance of a functional mitotic centrosome that supports the assembly of a bipolar mitotic spindle (PubMed:27137183). Enhances STUB1-mediated SMAD3 ubiquitination and degradation and facilitates STUB1-mediated inhibition of TGF-beta signaling (PubMed:24613385). Essential for STUB1-mediated ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg) during inflammation (PubMed:23973223). {ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256, ECO:0000303|PubMed:24012426, ECO:0000303|PubMed:26865365}.; FUNCTION: (Microbial infection) In case of rotavirus A infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. {ECO:0000269|PubMed:16537599}. |
P10114 | RAP2A | S129 | ochoa | Ras-related protein Rap-2a (EC 3.6.5.2) (RbBP-30) | Small GTP-binding protein which cycles between a GDP-bound inactive and a GTP-bound active form (PubMed:14966141, PubMed:15342639, PubMed:16246175, PubMed:16540189, PubMed:18930710, PubMed:20159449, PubMed:35293963). In its active form interacts with and regulates several effectors including MAP4K4, MINK1 and TNIK (PubMed:14966141, PubMed:15342639, PubMed:18930710, PubMed:20159449). Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development (PubMed:20159449). More generally, it is part of several signaling cascades and regulates cytoskeletal rearrangements, cell migration, cell adhesion and cell spreading (PubMed:14966141, PubMed:15342639, PubMed:16246175, PubMed:16540189, PubMed:18930710, PubMed:20159449, PubMed:35293963). {ECO:0000269|PubMed:14966141, ECO:0000269|PubMed:15342639, ECO:0000269|PubMed:16246175, ECO:0000269|PubMed:16540189, ECO:0000269|PubMed:18930710, ECO:0000269|PubMed:20159449, ECO:0000269|PubMed:35293963}. |
P10636 | MAPT | S579 | ochoa|psp | Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) | Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed:21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed:21985311, PubMed:32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization. {ECO:0000269|PubMed:21985311, ECO:0000269|PubMed:32961270}. |
P11021 | HSPA5 | S365 | ochoa | Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein) | Endoplasmic reticulum chaperone that plays a key role in protein folding and quality control in the endoplasmic reticulum lumen (PubMed:2294010, PubMed:23769672, PubMed:23990668, PubMed:28332555). Involved in the correct folding of proteins and degradation of misfolded proteins via its interaction with DNAJC10/ERdj5, probably to facilitate the release of DNAJC10/ERdj5 from its substrate (By similarity). Acts as a key repressor of the EIF2AK3/PERK and ERN1/IRE1-mediated unfolded protein response (UPR) (PubMed:11907036, PubMed:1550958, PubMed:19538957, PubMed:36739529). In the unstressed endoplasmic reticulum, recruited by DNAJB9/ERdj4 to the luminal region of ERN1/IRE1, leading to disrupt the dimerization of ERN1/IRE1, thereby inactivating ERN1/IRE1 (By similarity). Also binds and inactivates EIF2AK3/PERK in unstressed cells (PubMed:11907036). Accumulation of misfolded protein in the endoplasmic reticulum causes release of HSPA5/BiP from ERN1/IRE1 and EIF2AK3/PERK, allowing their homodimerization and subsequent activation (PubMed:11907036). Plays an auxiliary role in post-translational transport of small presecretory proteins across endoplasmic reticulum (ER). May function as an allosteric modulator for SEC61 channel-forming translocon complex, likely cooperating with SEC62 to enable the productive insertion of these precursors into SEC61 channel. Appears to specifically regulate translocation of precursors having inhibitory residues in their mature region that weaken channel gating. May also play a role in apoptosis and cell proliferation (PubMed:26045166). {ECO:0000250|UniProtKB:G3I8R9, ECO:0000250|UniProtKB:P20029, ECO:0000269|PubMed:11907036, ECO:0000269|PubMed:1550958, ECO:0000269|PubMed:19538957, ECO:0000269|PubMed:2294010, ECO:0000269|PubMed:23769672, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:26045166, ECO:0000269|PubMed:28332555, ECO:0000269|PubMed:29719251, ECO:0000269|PubMed:36739529}.; FUNCTION: (Microbial infection) Plays an important role in viral binding to the host cell membrane and entry for several flaviruses such as Dengue virus, Zika virus and Japanese encephalitis virus (PubMed:15098107, PubMed:28053106, PubMed:33432092). Acts as a component of the cellular receptor for Dengue virus serotype 2/DENV-2 on human liver cells (PubMed:15098107). {ECO:0000269|PubMed:15098107, ECO:0000269|PubMed:28053106, ECO:0000269|PubMed:33432092}.; FUNCTION: (Microbial infection) Acts as a receptor for CotH proteins expressed by fungi of the order mucorales, the causative agent of mucormycosis, which plays an important role in epithelial cell invasion by the fungi (PubMed:20484814, PubMed:24355926, PubMed:32487760). Acts as a receptor for R.delemar CotH3 in nasal epithelial cells, which may be an early step in rhinoorbital/cerebral mucormycosis (RCM) disease progression (PubMed:32487760). {ECO:0000269|PubMed:20484814, ECO:0000269|PubMed:24355926, ECO:0000269|PubMed:32487760}. |
P11137 | MAP2 | S1679 | psp | Microtubule-associated protein 2 (MAP-2) | The exact function of MAP2 is unknown but MAPs may stabilize the microtubules against depolymerization. They also seem to have a stiffening effect on microtubules. |
P11137 | MAP2 | S1710 | psp | Microtubule-associated protein 2 (MAP-2) | The exact function of MAP2 is unknown but MAPs may stabilize the microtubules against depolymerization. They also seem to have a stiffening effect on microtubules. |
P11142 | HSPA8 | S340 | ochoa | Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8) (Heat shock protein family A member 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1) | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, chaperone-mediated autophagy, activation of proteolysis of misfolded proteins, formation and dissociation of protein complexes, and antigen presentation. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation (PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661, PubMed:2799391, PubMed:36586411). This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones (PubMed:12526792, PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661). The co-chaperones have been shown to not only regulate different steps of the ATPase cycle of HSP70, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation (PubMed:12526792, PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661). The affinity of HSP70 for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. HSP70 goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The HSP70-associated co-chaperones are of three types: J-domain co-chaperones HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24121476, PubMed:24318877, PubMed:26865365, PubMed:27474739). Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70 (PubMed:12526792). Acts as a repressor of transcriptional activation. Inhibits the transcriptional coactivator activity of CITED1 on Smad-mediated transcription. Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex. Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:10722728, PubMed:11276205). Substrate recognition component in chaperone-mediated autophagy (CMA), a selective protein degradation process that mediates degradation of proteins with a -KFERQ motif: HSPA8/HSC70 specifically recognizes and binds cytosolic proteins bearing a -KFERQ motif and promotes their recruitment to the surface of the lysosome where they bind to lysosomal protein LAMP2 (PubMed:11559757, PubMed:2799391, PubMed:36586411). KFERQ motif-containing proteins are eventually transported into the lysosomal lumen where they are degraded (PubMed:11559757, PubMed:2799391, PubMed:36586411). In conjunction with LAMP2, facilitates MHC class II presentation of cytoplasmic antigens by guiding antigens to the lysosomal membrane for interaction with LAMP2 which then elicits MHC class II presentation of peptides to the cell membrane (PubMed:15894275). Participates in the ER-associated degradation (ERAD) quality control pathway in conjunction with J domain-containing co-chaperones and the E3 ligase STUB1 (PubMed:23990462). It is recruited to clathrin-coated vesicles through its interaction with DNAJC6 leading to activation of HSPA8/HSC70 ATPase activity and therefore uncoating of clathrin-coated vesicles (By similarity). {ECO:0000250|UniProtKB:P19120, ECO:0000269|PubMed:10722728, ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:11559757, ECO:0000269|PubMed:12526792, ECO:0000269|PubMed:15894275, ECO:0000269|PubMed:21148293, ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488, ECO:0000269|PubMed:23990462, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24732912, ECO:0000269|PubMed:27474739, ECO:0000269|PubMed:27916661, ECO:0000269|PubMed:2799391, ECO:0000269|PubMed:36586411, ECO:0000303|PubMed:24121476, ECO:0000303|PubMed:26865365}. |
P15880 | RPS2 | S264 | ochoa | Small ribosomal subunit protein uS5 (40S ribosomal protein S2) (40S ribosomal protein S4) (Protein LLRep3) | Component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). The small ribosomal subunit (SSU) binds messenger RNAs (mRNAs) and translates the encoded message by selecting cognate aminoacyl-transfer RNA (tRNA) molecules (PubMed:23636399). The large subunit (LSU) contains the ribosomal catalytic site termed the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds, thereby polymerizing the amino acids delivered by tRNAs into a polypeptide chain (PubMed:23636399). The nascent polypeptides leave the ribosome through a tunnel in the LSU and interact with protein factors that function in enzymatic processing, targeting, and the membrane insertion of nascent chains at the exit of the ribosomal tunnel (PubMed:23636399). Plays a role in the assembly and function of the 40S ribosomal subunit (By similarity). Mutations in this protein affects the control of translational fidelity (By similarity). Involved in nucleolar processing of pre-18S ribosomal RNA and ribosome assembly (By similarity). {ECO:0000250|UniProtKB:P25443, ECO:0000269|PubMed:23636399}. |
P16144 | ITGB4 | S1356 | ochoa|psp | Integrin beta-4 (GP150) (CD antigen CD104) | Integrin alpha-6/beta-4 is a receptor for laminin. Plays a critical structural role in the hemidesmosome of epithelial cells. Is required for the regulation of keratinocyte polarity and motility. ITGA6:ITGB4 binds to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB signaling (PubMed:20682778). ITGA6:ITGB4 binds to IGF1 and this binding is essential for IGF1 signaling (PubMed:22351760). ITGA6:ITGB4 binds to IGF2 and this binding is essential for IGF2 signaling (PubMed:28873464). {ECO:0000269|PubMed:12482924, ECO:0000269|PubMed:19403692, ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:22351760, ECO:0000269|PubMed:28873464}. |
P16298 | PPP3CB | S116 | ochoa | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform) (CNA beta) | Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals (PubMed:19154138, PubMed:25720963, PubMed:26794871, PubMed:32753672). Dephosphorylates TFEB in response to lysosomal Ca(2+) release, resulting in TFEB nuclear translocation and stimulation of lysosomal biogenesis (PubMed:25720963, PubMed:32753672). Dephosphorylates and activates transcription factor NFATC1 (PubMed:19154138). Dephosphorylates and inactivates transcription factor ELK1 (PubMed:19154138). Dephosphorylates DARPP32 (PubMed:19154138). Negatively regulates MAP3K14/NIK signaling via inhibition of nuclear translocation of the transcription factors RELA and RELB (By similarity). May play a role in skeletal muscle fiber type specification (By similarity). {ECO:0000250|UniProtKB:P48453, ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:25720963, ECO:0000269|PubMed:26794871, ECO:0000269|PubMed:32753672}. |
P21796 | VDAC1 | S35 | ochoa | Non-selective voltage-gated ion channel VDAC1 (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM) (Voltage-dependent anion-selective channel protein 1) (VDAC-1) (hVDAC1) | Non-selective voltage-gated ion channel that mediates the transport of anions and cations through the mitochondrion outer membrane and plasma membrane (PubMed:10661876, PubMed:11845315, PubMed:18755977, PubMed:30061676, PubMed:8420959). The channel at the outer mitochondrial membrane allows diffusion of small hydrophilic molecules; in the plasma membrane it is involved in cell volume regulation and apoptosis (PubMed:10661876, PubMed:11845315, PubMed:18755977, PubMed:8420959). It adopts an open conformation at low or zero membrane potential and a closed conformation at potentials above 30-40 mV (PubMed:10661876, PubMed:18755977, PubMed:8420959). The open state has a weak anion selectivity whereas the closed state is cation-selective (PubMed:18755977, PubMed:8420959). Binds various signaling molecules, including the sphingolipid ceramide, the phospholipid phosphatidylcholine, and the sterols cholesterol and oxysterol (PubMed:18755977, PubMed:31015432). In depolarized mitochondria, acts downstream of PRKN and PINK1 to promote mitophagy or prevent apoptosis; polyubiquitination by PRKN promotes mitophagy, while monoubiquitination by PRKN decreases mitochondrial calcium influx which ultimately inhibits apoptosis (PubMed:32047033). May participate in the formation of the permeability transition pore complex (PTPC) responsible for the release of mitochondrial products that triggers apoptosis (PubMed:15033708, PubMed:25296756). May mediate ATP export from cells (PubMed:30061676). Part of a complex composed of HSPA9, ITPR1 and VDAC1 that regulates mitochondrial calcium-dependent apoptosis by facilitating calcium transport from the ER lumen to the mitochondria intermembrane space thus providing calcium for the downstream calcium channel MCU that directly releases it into mitochondria matrix (By similarity). Mediates cytochrome c efflux (PubMed:20230784). {ECO:0000250|UniProtKB:Q60932, ECO:0000269|PubMed:10661876, ECO:0000269|PubMed:11845315, ECO:0000269|PubMed:15033708, ECO:0000269|PubMed:18755977, ECO:0000269|PubMed:20230784, ECO:0000269|PubMed:25296756, ECO:0000269|PubMed:30061676, ECO:0000269|PubMed:31015432, ECO:0000269|PubMed:32047033, ECO:0000269|PubMed:8420959}.; FUNCTION: Catalyzes the scrambling of phospholipids across the outer mitochondrial membrane; the mechanism is unrelated to channel activity and is capable of translocating both anionic and zwitterionic phospholipids. {ECO:0000269|PubMed:38065946}. |
P21817 | RYR1 | S3566 | ochoa | Ryanodine receptor 1 (RYR-1) (RyR1) (Skeletal muscle calcium release channel) (Skeletal muscle ryanodine receptor) (Skeletal muscle-type ryanodine receptor) (Type 1 ryanodine receptor) | Cytosolic calcium-activated calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytosol and thereby plays a key role in triggering muscle contraction following depolarization of T-tubules (PubMed:11741831, PubMed:16163667, PubMed:18268335, PubMed:18650434, PubMed:26115329). Repeated very high-level exercise increases the open probability of the channel and leads to Ca(2+) leaking into the cytoplasm (PubMed:18268335). Can also mediate the release of Ca(2+) from intracellular stores in neurons, and may thereby promote prolonged Ca(2+) signaling in the brain. Required for normal embryonic development of muscle fibers and skeletal muscle. Required for normal heart morphogenesis, skin development and ossification during embryogenesis (By similarity). {ECO:0000250|UniProtKB:E9PZQ0, ECO:0000269|PubMed:18268335, ECO:0000269|PubMed:18650434, ECO:0000269|PubMed:26115329, ECO:0000305|PubMed:11741831, ECO:0000305|PubMed:16163667}. |
P27816 | MAP4 | S616 | ochoa | Microtubule-associated protein 4 (MAP-4) | Non-neuronal microtubule-associated protein. Promotes microtubule assembly. {ECO:0000269|PubMed:10791892, ECO:0000269|PubMed:34782749}. |
P27816 | MAP4 | S941 | ochoa | Microtubule-associated protein 4 (MAP-4) | Non-neuronal microtubule-associated protein. Promotes microtubule assembly. {ECO:0000269|PubMed:10791892, ECO:0000269|PubMed:34782749}. |
P33993 | MCM7 | S365 | psp | DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog) (P1.1-MCM3) | Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:25661590, PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232, PubMed:9305914). The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (PubMed:32453425). Required for S-phase checkpoint activation upon UV-induced damage. {ECO:0000269|PubMed:15210935, ECO:0000269|PubMed:15538388, ECO:0000269|PubMed:25661590, ECO:0000269|PubMed:32453425, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:34700328, ECO:0000269|PubMed:35585232, ECO:0000269|PubMed:9305914}. |
P48454 | PPP3CC | S103 | ochoa | Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin, testis-specific catalytic subunit) (Calmodulin-dependent calcineurin A subunit gamma isoform) | Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals. Dephosphorylates and activates transcription factor NFATC1. Dephosphorylates and inactivates transcription factor ELK1. Dephosphorylates DARPP32. {ECO:0000269|PubMed:19154138}. |
P49116 | NR2C2 | S46 | ochoa | Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4) | Orphan nuclear receptor that can act as a repressor or activator of transcription. An important repressor of nuclear receptor signaling pathways such as retinoic acid receptor, retinoid X, vitamin D3 receptor, thyroid hormone receptor and estrogen receptor pathways. May regulate gene expression during the late phase of spermatogenesis. Together with NR2C1, forms the core of the DRED (direct repeat erythroid-definitive) complex that represses embryonic and fetal globin transcription including that of GATA1. Binds to hormone response elements (HREs) consisting of two 5'-AGGTCA-3' half site direct repeat consensus sequences. Plays a fundamental role in early embryonic development and embryonic stem cells. Required for normal spermatogenesis and cerebellum development. Appears to be important for neurodevelopmentally regulated behavior (By similarity). Activates transcriptional activity of LHCG. Antagonist of PPARA-mediated transactivation. {ECO:0000250, ECO:0000269|PubMed:10347174, ECO:0000269|PubMed:10644740, ECO:0000269|PubMed:17974920, ECO:0000269|PubMed:7779113, ECO:0000269|PubMed:9556573}. |
P49327 | FASN | S2473 | ochoa | Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)] | Fatty acid synthetase is a multifunctional enzyme that catalyzes the de novo biosynthesis of long-chain saturated fatty acids starting from acetyl-CoA and malonyl-CoA in the presence of NADPH. This multifunctional protein contains 7 catalytic activities and a site for the binding of the prosthetic group 4'-phosphopantetheine of the acyl carrier protein ([ACP]) domain. {ECO:0000269|PubMed:16215233, ECO:0000269|PubMed:16969344, ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}.; FUNCTION: (Microbial infection) Fatty acid synthetase activity is required for SARS coronavirus-2/SARS-CoV-2 replication. {ECO:0000269|PubMed:34320401}. |
P49792 | RANBP2 | S1953 | ochoa | E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) | E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I (PubMed:11792325, PubMed:12032081, PubMed:15378033, PubMed:15931224, PubMed:22194619). Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates (PubMed:7775481). Binds single-stranded RNA (in vitro) (PubMed:7775481). May bind DNA (PubMed:7775481). Component of the nuclear export pathway (PubMed:10078529). Specific docking site for the nuclear export factor exportin-1 (PubMed:10078529). Inhibits EIF4E-dependent mRNA export (PubMed:22902403). Sumoylates PML at 'Lys-490' which is essential for the proper assembly of PML-NB (PubMed:22155184). Recruits BICD2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during G2 phase of cell cycle (PubMed:20386726). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity (PubMed:20676357, PubMed:23353830). {ECO:0000269|PubMed:11792325, ECO:0000269|PubMed:12032081, ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22194619, ECO:0000269|PubMed:22902403, ECO:0000269|PubMed:23353830, ECO:0000269|PubMed:7775481, ECO:0000303|PubMed:10078529}. |
P50395 | GDI2 | S61 | ochoa | Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2) | GDP-dissociation inhibitor preventing the GDP to GTP exchange of most Rab proteins. By keeping these small GTPases in their inactive GDP-bound form regulates intracellular membrane trafficking (PubMed:25860027). Negatively regulates protein transport to the cilium and ciliogenesis through the inhibition of RAB8A (PubMed:25860027). {ECO:0000269|PubMed:25860027}. |
P78352 | DLG4 | S561 | psp | Disks large homolog 4 (Postsynaptic density protein 95) (PSD-95) (Synapse-associated protein 90) (SAP-90) (SAP90) | Postsynaptic scaffolding protein that plays a critical role in synaptogenesis and synaptic plasticity by providing a platform for the postsynaptic clustering of crucial synaptic proteins. Interacts with the cytoplasmic tail of NMDA receptor subunits and shaker-type potassium channels. Required for synaptic plasticity associated with NMDA receptor signaling. Overexpression or depletion of DLG4 changes the ratio of excitatory to inhibitory synapses in hippocampal neurons. May reduce the amplitude of ASIC3 acid-evoked currents by retaining the channel intracellularly. May regulate the intracellular trafficking of ADR1B. Also regulates AMPA-type glutamate receptor (AMPAR) immobilization at postsynaptic density keeping the channels in an activated state in the presence of glutamate and preventing synaptic depression (By similarity). Under basal conditions, cooperates with FYN to stabilize palmitoyltransferase ZDHHC5 at the synaptic membrane through FYN-mediated phosphorylation of ZDHHC5 and its subsequent inhibition of association with endocytic proteins (PubMed:26334723). {ECO:0000250|UniProtKB:Q62108, ECO:0000269|PubMed:26334723}. |
Q02487 | DSC2 | S864 | ochoa | Desmocollin-2 (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III) | A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:33596089). Promotes timely incorporation of DSG2 into desmosome intercellular junctions and promotes interaction of desmosome cell junctions with intermediate filament cytokeratin, via modulation of DSP phosphorylation (PubMed:33596089). Plays an important role in desmosome-mediated maintenance of intestinal epithelial cell intercellular adhesion strength and barrier function (PubMed:33596089). Positively regulates wound healing of intestinal mucosa via promotion of epithelial cell migration, and also plays a role in mechanotransduction of force between intestinal epithelial cells and extracellular matrix (PubMed:31967937). May contribute to epidermal cell positioning (stratification) by mediating differential adhesiveness between cells that express different isoforms. May promote p38MAPK signaling activation that facilitates keratinocyte migration (By similarity). {ECO:0000250|UniProtKB:P55292, ECO:0000269|PubMed:31967937, ECO:0000269|PubMed:33596089}. |
Q04721 | NOTCH2 | S2070 | ochoa | Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] | Functions as a receptor for membrane-bound ligands Jagged-1 (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1) to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus (PubMed:21378985, PubMed:21378989). Affects the implementation of differentiation, proliferation and apoptotic programs (By similarity). Involved in bone remodeling and homeostasis. In collaboration with RELA/p65 enhances NFATc1 promoter activity and positively regulates RANKL-induced osteoclast differentiation (PubMed:29149593). Positively regulates self-renewal of liver cancer cells (PubMed:25985737). {ECO:0000250|UniProtKB:O35516, ECO:0000269|PubMed:21378985, ECO:0000269|PubMed:21378989, ECO:0000269|PubMed:25985737, ECO:0000269|PubMed:29149593}. |
Q08209 | PPP3CA | S107 | ochoa | Protein phosphatase 3 catalytic subunit alpha (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin A alpha) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha) (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) | Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals (PubMed:15671020, PubMed:18838687, PubMed:19154138, PubMed:23468591, PubMed:30254215). Many of the substrates contain a PxIxIT motif and/or a LxVP motif (PubMed:17498738, PubMed:17502104, PubMed:22343722, PubMed:23468591, PubMed:27974827). In response to increased Ca(2+) levels, dephosphorylates and activates phosphatase SSH1 which results in cofilin dephosphorylation (PubMed:15671020). In response to increased Ca(2+) levels following mitochondrial depolarization, dephosphorylates DNM1L inducing DNM1L translocation to the mitochondrion (PubMed:18838687). Positively regulates the CACNA1B/CAV2.2-mediated Ca(2+) release probability at hippocampal neuronal soma and synaptic terminals (By similarity). Dephosphorylates heat shock protein HSPB1 (By similarity). Dephosphorylates and activates transcription factor NFATC1 (PubMed:19154138). In response to increased Ca(2+) levels, regulates NFAT-mediated transcription probably by dephosphorylating NFAT and promoting its nuclear translocation (PubMed:26248042). Dephosphorylates and inactivates transcription factor ELK1 (PubMed:19154138). Dephosphorylates DARPP32 (PubMed:19154138). May dephosphorylate CRTC2 at 'Ser-171' resulting in CRTC2 dissociation from 14-3-3 proteins (PubMed:30611118). Dephosphorylates transcription factor TFEB at 'Ser-211' following Coxsackievirus B3 infection, promoting nuclear translocation (PubMed:33691586). Required for postnatal development of the nephrogenic zone and superficial glomeruli in the kidneys, cell cycle homeostasis in the nephrogenic zone, and ultimately normal kidney function (By similarity). Plays a role in intracellular AQP2 processing and localization to the apical membrane in the kidney, may thereby be required for efficient kidney filtration (By similarity). Required for secretion of salivary enzymes amylase, peroxidase, lysozyme and sialic acid via formation of secretory vesicles in the submandibular glands (By similarity). Required for calcineurin activity and homosynaptic depotentiation in the hippocampus (By similarity). Required for normal differentiation and survival of keratinocytes and therefore required for epidermis superstructure formation (By similarity). Positively regulates osteoblastic bone formation, via promotion of osteoblast differentiation (By similarity). Positively regulates osteoclast differentiation, potentially via NFATC1 signaling (By similarity). May play a role in skeletal muscle fiber type specification, potentially via NFATC1 signaling (By similarity). Negatively regulates MAP3K14/NIK signaling via inhibition of nuclear translocation of the transcription factors RELA and RELB (By similarity). Required for antigen-specific T-cell proliferation response (By similarity). Dephosphorylates KLHL3, promoting the interaction between KLHL3 and WNK4 and subsequent degradation of WNK4 (PubMed:30718414). Negatively regulates SLC9A1 activity (PubMed:31375679). {ECO:0000250|UniProtKB:P48452, ECO:0000250|UniProtKB:P63328, ECO:0000250|UniProtKB:P63329, ECO:0000269|PubMed:15671020, ECO:0000269|PubMed:17498738, ECO:0000269|PubMed:17502104, ECO:0000269|PubMed:18838687, ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:22343722, ECO:0000269|PubMed:23468591, ECO:0000269|PubMed:26248042, ECO:0000269|PubMed:27974827, ECO:0000269|PubMed:30254215, ECO:0000269|PubMed:30611118, ECO:0000269|PubMed:30718414, ECO:0000269|PubMed:31375679, ECO:0000269|PubMed:33691586}. |
Q12815 | TROAP | S156 | ochoa | Tastin (Trophinin-assisting protein) (Trophinin-associated protein) | Could be involved with bystin and trophinin in a cell adhesion molecule complex that mediates an initial attachment of the blastocyst to uterine epithelial cells at the time of the embryo implantation. |
Q12882 | DPYD | S587 | ochoa | Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) | Involved in pyrimidine base degradation (PubMed:1512248). Catalyzes the reduction of uracil and thymine (PubMed:1512248). Also involved the degradation of the chemotherapeutic drug 5-fluorouracil (PubMed:1512248). {ECO:0000269|PubMed:1512248}. |
Q13136 | PPFIA1 | S763 | ochoa | Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1) | May regulate the disassembly of focal adhesions. May localize receptor-like tyrosine phosphatases type 2A at specific sites on the plasma membrane, possibly regulating their interaction with the extracellular environment and their association with substrates. {ECO:0000269|PubMed:7796809}. |
Q13470 | TNK1 | S255 | ochoa | Non-receptor tyrosine-protein kinase TNK1 (EC 2.7.10.2) (CD38 negative kinase 1) | Involved in negative regulation of cell growth. Has tumor suppressor properties. Plays a negative regulatory role in the Ras-MAPK pathway. May function in signaling pathways utilized broadly during fetal development and more selectively in adult tissues and in cells of the lymphohematopoietic system. Could specifically be involved in phospholipid signal transduction. {ECO:0000269|PubMed:10873601, ECO:0000269|PubMed:18974114}. |
Q13868 | EXOSC2 | S175 | ochoa | Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4) | Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC2 as peripheral part of the Exo-9 complex stabilizes the hexameric ring of RNase PH-domain subunits through contacts with EXOSC4 and EXOSC7. {ECO:0000269|PubMed:17545563}. |
Q14574 | DSC3 | S859 | ochoa | Desmocollin-3 (Cadherin family member 3) (Desmocollin-4) (HT-CP) | A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (By similarity). Required for cell-cell adhesion in the epidermis, as a result required for the maintenance of the dermal cohesion and the dermal barrier function (PubMed:19717567). Required for cell-cell adhesion of epithelial cell layers surrounding the telogen hair club, as a result plays an important role in telogen hair shaft anchorage (By similarity). Essential for successful completion of embryo compaction and embryo development (By similarity). {ECO:0000250|UniProtKB:P55850, ECO:0000269|PubMed:19717567}. |
Q15717 | ELAVL1 | S242 | psp | ELAV-like protein 1 (Hu-antigen R) (HuR) | RNA-binding protein that binds to the 3'-UTR region of mRNAs and increases their stability (PubMed:14517288, PubMed:18285462, PubMed:31358969). Involved in embryonic stem cell (ESC) differentiation: preferentially binds mRNAs that are not methylated by N6-methyladenosine (m6A), stabilizing them, promoting ESC differentiation (By similarity). Has also been shown to be capable of binding to m6A-containing mRNAs and contributes to MYC stability by binding to m6A-containing MYC mRNAs (PubMed:32245947). Binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs (PubMed:14731398, PubMed:17632515, PubMed:18285462, PubMed:23519412, PubMed:8626503). Binds avidly to the AU-rich element in FOS and IL3/interleukin-3 mRNAs. In the case of the FOS AU-rich element, binds to a core element of 27 nucleotides that contain AUUUA, AUUUUA, and AUUUUUA motifs. Binds preferentially to the 5'-UUUU[AG]UUU-3' motif in vitro (PubMed:8626503). With ZNF385A, binds the 3'-UTR of p53/TP53 mRNA to control their nuclear export induced by CDKN2A. Hence, may regulate p53/TP53 expression and mediate in part the CDKN2A anti-proliferative activity. May also bind with ZNF385A the CCNB1 mRNA (By similarity). Increases the stability of the leptin mRNA harboring an AU-rich element (ARE) in its 3' UTR (PubMed:29180010). {ECO:0000250|UniProtKB:P70372, ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:14731398, ECO:0000269|PubMed:17632515, ECO:0000269|PubMed:18285462, ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:23519412, ECO:0000269|PubMed:29180010, ECO:0000269|PubMed:31358969, ECO:0000269|PubMed:32245947, ECO:0000269|PubMed:8626503}. |
Q16831 | UPP1 | S61 | ochoa | Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3) | Catalyzes the reversible phosphorylytic cleavage of uridine to uracil and ribose-1-phosphate which can then be utilized as carbon and energy sources or in the rescue of pyrimidine bases for nucleotide synthesis (PubMed:7488099). Shows broad substrate specificity and can also accept deoxyuridine and other analogous compounds (Probable). {ECO:0000269|PubMed:7488099, ECO:0000305|PubMed:13737038}. |
Q16832 | DDR2 | S758 | ochoa | Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) | Tyrosine kinase involved in the regulation of tissues remodeling (PubMed:30449416). It functions as a cell surface receptor for fibrillar collagen and regulates cell differentiation, remodeling of the extracellular matrix, cell migration and cell proliferation. Required for normal bone development. Regulates osteoblast differentiation and chondrocyte maturation via a signaling pathway that involves MAP kinases and leads to the activation of the transcription factor RUNX2. Regulates remodeling of the extracellular matrix by up-regulation of the collagenases MMP1, MMP2 and MMP13, and thereby facilitates cell migration and tumor cell invasion. Promotes fibroblast migration and proliferation, and thereby contributes to cutaneous wound healing. {ECO:0000269|PubMed:16186104, ECO:0000269|PubMed:16186108, ECO:0000269|PubMed:17665456, ECO:0000269|PubMed:18201965, ECO:0000269|PubMed:20004161, ECO:0000269|PubMed:20564243, ECO:0000269|PubMed:20734453, ECO:0000269|PubMed:30449416, ECO:0000269|PubMed:9659899}. |
Q17R98 | ZNF827 | S477 | ochoa | Zinc finger protein 827 | As part of a ribonucleoprotein complex composed at least of HNRNPK, HNRNPL and the circular RNA circZNF827 that nucleates the complex on chromatin, may negatively regulate the transcription of genes involved in neuronal differentiation (PubMed:33174841). Could also recruit the nucleosome remodeling and histone deacetylase/NuRD complex to telomeric regions of chromosomes to regulate chromatin remodeling as part of telomere maintenance (PubMed:25150861). {ECO:0000269|PubMed:25150861, ECO:0000269|PubMed:33174841}. |
Q2KHM9 | KIAA0753 | S772 | ochoa | Protein moonraker (MNR) (OFD1- and FOPNL-interacting protein) | Involved in centriole duplication (PubMed:24613305, PubMed:26297806). Positively regulates CEP63 centrosomal localization (PubMed:24613305, PubMed:26297806). Required for WDR62 centrosomal localization and promotes the centrosomal localization of CDK2 (PubMed:24613305, PubMed:26297806). May play a role in cilium assembly. {ECO:0000269|PubMed:24613305, ECO:0000269|PubMed:26297806, ECO:0000269|PubMed:28220259}. |
Q53GQ0 | HSD17B12 | S58 | ochoa | Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62) (Short chain dehydrogenase/reductase family 12C member 1) | Catalyzes the second of the four reactions of the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of two carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. This enzyme has a 3-ketoacyl-CoA reductase activity, reducing 3-ketoacyl-CoA to 3-hydroxyacyl-CoA, within each cycle of fatty acid elongation. Thereby, it may participate in the production of VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. May also catalyze the transformation of estrone (E1) into estradiol (E2) and play a role in estrogen formation. {ECO:0000269|PubMed:12482854, ECO:0000269|PubMed:16166196}. |
Q5VT06 | CEP350 | S1061 | ochoa | Centrosome-associated protein 350 (Cep350) (Centrosome-associated protein of 350 kDa) | Plays an essential role in centriole growth by stabilizing a procentriolar seed composed of at least, SASS6 and CPAP (PubMed:19052644). Required for anchoring microtubules to the centrosomes and for the integrity of the microtubule network (PubMed:16314388, PubMed:17878239, PubMed:28659385). Recruits PPARA to discrete subcellular compartments and thereby modulates PPARA activity (PubMed:15615782). Required for ciliation (PubMed:28659385). {ECO:0000269|PubMed:15615782, ECO:0000269|PubMed:16314388, ECO:0000269|PubMed:17878239, ECO:0000269|PubMed:19052644, ECO:0000269|PubMed:28659385}. |
Q7Z3J3 | RGPD4 | S978 | ochoa | RanBP2-like and GRIP domain-containing protein 4 | None |
Q7Z699 | SPRED1 | S105 | ochoa|psp | Sprouty-related, EVH1 domain-containing protein 1 (Spred-1) (hSpred1) | Tyrosine kinase substrate that inhibits growth-factor-mediated activation of MAP kinase (By similarity). Negatively regulates hematopoiesis of bone marrow (By similarity). Inhibits fibroblast growth factor (FGF)-induced retinal lens fiber differentiation, probably by inhibiting FGF-mediated phosphorylation of ERK1/2 (By similarity). Attenuates actin stress fiber formation via inhibition of TESK1-mediated phosphorylation of cofilin (PubMed:18216281). Inhibits TGFB-induced epithelial-to-mesenchymal transition in lens epithelial cells (By similarity). {ECO:0000250|UniProtKB:Q924S8, ECO:0000269|PubMed:18216281}. |
Q86TC9 | MYPN | S960 | ochoa | Myopalladin (145 kDa sarcomeric protein) | Component of the sarcomere that tethers together nebulin (skeletal muscle) and nebulette (cardiac muscle) to alpha-actinin, at the Z lines. {ECO:0000269|PubMed:11309420}. |
Q86VI3 | IQGAP3 | S539 | ochoa | Ras GTPase-activating-like protein IQGAP3 | None |
Q86WH2 | RASSF3 | S137 | ochoa | Ras association domain-containing protein 3 | None |
Q86XI6 | PPP1R3B | S261 | ochoa | Protein phosphatase 1 regulatory subunit 3B (Hepatic glycogen-targeting protein phosphatase 1 regulatory subunit GL) (Protein phosphatase 1 regulatory subunit 4) (PP1 subunit R4) (Protein phosphatase 1 subunit GL) (PTG) | Acts as a glycogen-targeting subunit for phosphatase PP1. Facilitates interaction of the PP1 with enzymes of the glycogen metabolism and regulates its activity. Suppresses the rate at which PP1 dephosphorylates (inactivates) glycogen phosphorylase and enhances the rate at which it activates glycogen synthase and therefore limits glycogen breakdown. Its activity is inhibited by PYGL, resulting in inhibition of the glycogen synthase and glycogen phosphorylase phosphatase activities of PP1. Dramatically increases basal and insulin-stimulated glycogen synthesis upon overexpression in hepatocytes (By similarity). {ECO:0000250}. |
Q8IWE5 | PLEKHM2 | S559 | ochoa | Pleckstrin homology domain-containing family M member 2 (PH domain-containing family M member 2) (Salmonella-induced filaments A and kinesin-interacting protein) (SifA and kinesin-interacting protein) | Plays a role in lysosomes movement and localization at the cell periphery acting as an effector of ARL8B. Required for ARL8B to exert its effects on lysosome location, recruits kinesin-1 to lysosomes and hence direct their movement toward microtubule plus ends. Binding to ARL8B provides a link from lysosomal membranes to plus-end-directed motility (PubMed:22172677, PubMed:24088571, PubMed:25898167, PubMed:28325809). Critical factor involved in NK cell-mediated cytotoxicity. Drives the polarization of cytolytic granules and microtubule-organizing centers (MTOCs) toward the immune synapse between effector NK lymphocytes and target cells (PubMed:24088571). Required for maintenance of the Golgi apparatus organization (PubMed:22172677). May play a role in membrane tubulation (PubMed:15905402). {ECO:0000269|PubMed:15905402, ECO:0000269|PubMed:22172677, ECO:0000269|PubMed:24088571, ECO:0000269|PubMed:25898167, ECO:0000269|PubMed:28325809}. |
Q8IWT3 | CUL9 | S976 | ochoa | Cullin-9 (CUL-9) (UbcH7-associated protein 1) (p53-associated parkin-like cytoplasmic protein) | Core component of a Cul9-RING ubiquitin-protein ligase complex composed of CUL9 and RBX1 (PubMed:38605244). The CUL9-RBX1 complex mediates ubiquitination and subsequent degradation of BIRC5 and is required to maintain microtubule dynamics and genome integrity. Acts downstream of the 3M complex, which inhibits the ubiquitination of BIRC5 (PubMed:24793696). The CUL9-RBX1 complex also mediates mono-ubiquitination of p53/TP53 (PubMed:38605244). Acts as a cytoplasmic anchor protein in p53/TP53-associated protein complex. Regulates the subcellular localization of p53/TP53 and its subsequent function (PubMed:12526791, PubMed:17332328). Ubiquitinates apurinic/apyrimidinic endodeoxyribonuclease APEX2 (PubMed:38605244). Ubiquitination by the CUL9-RBX1 complex is predominantly mediated by E2 ubiquitin-conjugating enzymes UBE2L3 and UBE2D2 (PubMed:38605244). {ECO:0000269|PubMed:12526791, ECO:0000269|PubMed:17332328, ECO:0000269|PubMed:24793696, ECO:0000269|PubMed:38605244}. |
Q8NF50 | DOCK8 | S1279 | ochoa | Dedicator of cytokinesis protein 8 | Guanine nucleotide exchange factor (GEF) which specifically activates small GTPase CDC42 by exchanging bound GDP for free GTP (PubMed:22461490, PubMed:28028151). During immune responses, required for interstitial dendritic cell (DC) migration by locally activating CDC42 at the leading edge membrane of DC (By similarity). Required for CD4(+) T-cell migration in response to chemokine stimulation by promoting CDC42 activation at T cell leading edge membrane (PubMed:28028151). Is involved in NK cell cytotoxicity by controlling polarization of microtubule-organizing center (MTOC), and possibly regulating CCDC88B-mediated lytic granule transport to MTOC during cell killing (PubMed:25762780). {ECO:0000250|UniProtKB:Q8C147, ECO:0000269|PubMed:22461490, ECO:0000269|PubMed:25762780, ECO:0000269|PubMed:28028151}. |
Q8TDB6 | DTX3L | S202 | ochoa | E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2) | E3 ubiquitin-protein ligase which, in association with ADP-ribosyltransferase PARP9, plays a role in DNA damage repair and in interferon-mediated antiviral responses (PubMed:12670957, PubMed:19818714, PubMed:23230272, PubMed:26479788). Monoubiquitinates several histones, including histone H2A, H2B, H3 and H4 (PubMed:28525742). In response to DNA damage, mediates monoubiquitination of 'Lys-91' of histone H4 (H4K91ub1) (PubMed:19818714). The exact role of H4K91ub1 in DNA damage response is still unclear but it may function as a licensing signal for additional histone H4 post-translational modifications such as H4 'Lys-20' methylation (H4K20me) (PubMed:19818714). PARP1-dependent PARP9-DTX3L-mediated ubiquitination promotes the rapid and specific recruitment of 53BP1/TP53BP1, UIMC1/RAP80, and BRCA1 to DNA damage sites (PubMed:23230272). By monoubiquitinating histone H2B H2BC9/H2BJ and thereby promoting chromatin remodeling, positively regulates STAT1-dependent interferon-stimulated gene transcription and thus STAT1-mediated control of viral replication (PubMed:26479788). Independently of its catalytic activity, promotes the sorting of chemokine receptor CXCR4 from early endosome to lysosome following CXCL12 stimulation by reducing E3 ligase ITCH activity and thus ITCH-mediated ubiquitination of endosomal sorting complex required for transport ESCRT-0 components HGS and STAM (PubMed:24790097). In addition, required for the recruitment of HGS and STAM to early endosomes (PubMed:24790097). In association with PARP9, plays a role in antiviral responses by mediating 'Lys-48'-linked ubiquitination of encephalomyocarditis virus (EMCV) and human rhinovirus (HRV) C3 proteases and thus promoting their proteasomal-mediated degradation (PubMed:26479788). {ECO:0000269|PubMed:12670957, ECO:0000269|PubMed:19818714, ECO:0000269|PubMed:23230272, ECO:0000269|PubMed:24790097, ECO:0000269|PubMed:26479788, ECO:0000269|PubMed:28525742}. |
Q8TER5 | ARHGEF40 | S255 | ochoa | Rho guanine nucleotide exchange factor 40 (Protein SOLO) | May act as a guanine nucleotide exchange factor (GEF). {ECO:0000250}. |
Q8WVM8 | SCFD1 | S303 | ochoa|psp | Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2) | Plays a role in SNARE-pin assembly and Golgi-to-ER retrograde transport via its interaction with COG4. Involved in vesicular transport between the endoplasmic reticulum and the Golgi (By similarity). {ECO:0000250}. |
Q96A47 | ISL2 | S279 | ochoa | Insulin gene enhancer protein ISL-2 (Islet-2) | Transcriptional factor that defines subclasses of motoneurons that segregate into columns in the spinal cord and select distinct axon pathways. {ECO:0000250}. |
Q96BI3 | APH1A | S110 | psp | Gamma-secretase subunit APH-1A (APH-1a) (Aph-1alpha) (Presenilin-stabilization factor) | Non-catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:12297508, PubMed:12522139, PubMed:12679784, PubMed:12763021, PubMed:25043039, PubMed:26280335, PubMed:30598546, PubMed:30630874). Required for normal gamma-secretase assembly (PubMed:12471034, PubMed:12522139, PubMed:12763021, PubMed:19369254). The gamma-secretase complex plays a role in Notch and Wnt signaling cascades and regulation of downstream processes via its role in processing key regulatory proteins, and by regulating cytosolic CTNNB1 levels (Probable). {ECO:0000269|PubMed:12297508, ECO:0000269|PubMed:12471034, ECO:0000269|PubMed:12522139, ECO:0000269|PubMed:12679784, ECO:0000269|PubMed:12763021, ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874, ECO:0000305}. |
Q96GG9 | DCUN1D1 | S59 | ochoa | DCN1-like protein 1 (DCNL1) (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Squamous cell carcinoma-related oncogene) | Part of an E3 ubiquitin ligase complex for neddylation (PubMed:18826954). Promotes neddylation of cullin components of E3 cullin-RING ubiquitin ligase complexes (PubMed:19617556, PubMed:23201271, PubMed:23401859, PubMed:26906416). Acts by binding to cullin-RBX1 complexes in the cytoplasm and promoting their nuclear translocation, enhancing recruitment of E2-NEDD8 (UBE2M-NEDD8) thioester to the complex, and optimizing the orientation of proteins in the complex to allow efficient transfer of NEDD8 from the E2 to the cullin substrates. Involved in the release of inhibitory effets of CAND1 on cullin-RING ligase E3 complex assembly and activity (PubMed:25349211, PubMed:28581483). Also acts as an oncogene facilitating malignant transformation and carcinogenic progression (By similarity). {ECO:0000250|UniProtKB:Q9QZ73, ECO:0000269|PubMed:18826954, ECO:0000269|PubMed:19617556, ECO:0000269|PubMed:23201271, ECO:0000269|PubMed:23401859, ECO:0000269|PubMed:25349211, ECO:0000269|PubMed:26906416, ECO:0000269|PubMed:28581483}. |
Q96MU7 | YTHDC1 | S424 | ochoa | YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B) | Regulator of alternative splicing that specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs (PubMed:25242552, PubMed:26318451, PubMed:26876937, PubMed:28984244). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in the efficiency of mRNA splicing, processing and stability (PubMed:25242552, PubMed:26318451). Acts as a key regulator of exon-inclusion or exon-skipping during alternative splicing via interaction with mRNA splicing factors SRSF3 and SRSF10 (PubMed:26876937). Specifically binds m6A-containing mRNAs and promotes recruitment of SRSF3 to its mRNA-binding elements adjacent to m6A sites, leading to exon-inclusion during alternative splicing (PubMed:26876937). In contrast, interaction with SRSF3 prevents interaction with SRSF10, a splicing factor that promotes exon skipping: this prevents SRSF10 from binding to its mRNA-binding sites close to m6A-containing regions, leading to inhibit exon skipping during alternative splicing (PubMed:26876937). May also regulate alternative splice site selection (PubMed:20167602). Also involved in nuclear export of m6A-containing mRNAs via interaction with SRSF3: interaction with SRSF3 facilitates m6A-containing mRNA-binding to both SRSF3 and NXF1, promoting mRNA nuclear export (PubMed:28984244). Involved in S-adenosyl-L-methionine homeostasis by regulating expression of MAT2A transcripts, probably by binding m6A-containing MAT2A mRNAs (By similarity). Also recognizes and binds m6A on other RNA molecules (PubMed:27602518). Involved in random X inactivation mediated by Xist RNA: recognizes and binds m6A-containing Xist and promotes transcription repression activity of Xist (PubMed:27602518). Also recognizes and binds m6A-containing single-stranded DNA (PubMed:32663306). Involved in germline development: required for spermatogonial development in males and oocyte growth and maturation in females, probably via its role in alternative splicing (By similarity). {ECO:0000250|UniProtKB:E9Q5K9, ECO:0000269|PubMed:20167602, ECO:0000269|PubMed:25242552, ECO:0000269|PubMed:26318451, ECO:0000269|PubMed:26876937, ECO:0000269|PubMed:27602518, ECO:0000269|PubMed:28984244, ECO:0000269|PubMed:32663306}. |
Q96P47 | AGAP3 | S121 | ochoa | Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 (AGAP-3) (CRAM-associated GTPase) (CRAG) (Centaurin-gamma-3) (Cnt-g3) (MR1-interacting protein) (MRIP-1) | GTPase-activating protein for the ADP ribosylation factor family (Potential). GTPase which may be involved in the degradation of expanded polyglutamine proteins through the ubiquitin-proteasome pathway. {ECO:0000269|PubMed:16461359, ECO:0000305}. |
Q96T17 | MAP7D2 | S273 | ochoa | MAP7 domain-containing protein 2 | Microtubule-stabilizing protein that plays a role in the control of cell motility and neurite outgrowth via direct binding to the microtubule (By similarity). Acts as a critical cofactor for kinesin transport. In the proximal axon, regulates kinesin-1 family members, KIF5A, KIF5B and KIF5C recruitment to microtubules and contributes to kinesin-1-mediated transport in the axons (By similarity). {ECO:0000250|UniProtKB:A2AG50, ECO:0000250|UniProtKB:D4A4L4}. |
Q99426 | TBCB | S65 | psp | Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B) | Binds to alpha-tubulin folding intermediates after their interaction with cytosolic chaperonin in the pathway leading from newly synthesized tubulin to properly folded heterodimer (PubMed:9265649). Involved in regulation of tubulin heterodimer dissociation. May function as a negative regulator of axonal growth (By similarity). {ECO:0000250|UniProtKB:Q9D1E6, ECO:0000269|PubMed:9265649}. |
Q99666 | RGPD5 | S977 | ochoa | RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2) (RanBP2-like 1/2) (RanBP2L1) (RanBP2L2) (Sperm membrane protein BS-63) | None |
Q9BZE9 | ASPSCR1 | S165 | ochoa | Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein) (Alveolar soft part sarcoma locus) (Renal papillary cell carcinoma protein 17) (UBX domain-containing protein 9) | Tethering protein that sequesters GLUT4-containing vesicles in the cytoplasm in the absence of insulin. Modulates the amount of GLUT4 that is available at the cell surface (By similarity). Enhances VCP methylation catalyzed by VCPKMT. {ECO:0000250, ECO:0000269|PubMed:23349634}. |
Q9BZV1 | UBXN6 | S96 | ochoa | UBX domain-containing protein 6 (UBX domain-containing protein 1) | May negatively regulate the ATPase activity of VCP, an ATP-driven segregase that associates with different cofactors to control a wide variety of cellular processes (PubMed:26475856). As a cofactor of VCP, it may play a role in the transport of CAV1 to lysosomes for degradation (PubMed:21822278, PubMed:23335559). It may also play a role in endoplasmic reticulum-associated degradation (ERAD) of misfolded proteins (PubMed:19275885). Together with VCP and other cofactors, it may play a role in macroautophagy, regulating for instance the clearance of damaged lysosomes (PubMed:27753622). {ECO:0000269|PubMed:19275885, ECO:0000269|PubMed:21822278, ECO:0000269|PubMed:23335559, ECO:0000269|PubMed:26475856, ECO:0000269|PubMed:27753622}. |
Q9C040 | TRIM2 | S428 | ochoa | Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2) | UBE2D1-dependent E3 ubiquitin-protein ligase that mediates the ubiquitination of NEFL and of phosphorylated BCL2L11. Plays a neuroprotective function. May play a role in neuronal rapid ischemic tolerance. Plays a role in antiviral immunity and limits New World arenavirus infection independently of its ubiquitin ligase activity (PubMed:24068738). {ECO:0000250|UniProtKB:Q9ESN6, ECO:0000269|PubMed:24068738}. |
Q9H165 | BCL11A | S86 | ochoa | BCL11 transcription factor A (B-cell CLL/lymphoma 11A) (B-cell lymphoma/leukemia 11A) (BCL-11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856) | Transcription factor (PubMed:16704730, PubMed:29606353). Associated with the BAF SWI/SNF chromatin remodeling complex (PubMed:23644491, PubMed:39607926). Binds to the 5'-TGACCA-3' sequence motif in regulatory regions of target genes, including a distal promoter of the HBG1 hemoglobin subunit gamma-1 gene (PubMed:29606353, PubMed:39423807). Involved in regulation of the developmental switch from gamma- to beta-globin, probably via direct repression of HBG1; hence indirectly repressing fetal hemoglobin (HbF) level (PubMed:26375765, PubMed:29606353, PubMed:39423807, PubMed:39607926). Involved in brain development (PubMed:27453576). May play a role in hematopoiesis (By similarity). Essential factor in lymphopoiesis required for B-cell formation in fetal liver (By similarity). May function as a modulator of the transcriptional repression activity of NR2F2 (By similarity). {ECO:0000250|UniProtKB:Q9QYE3, ECO:0000269|PubMed:16704730, ECO:0000269|PubMed:23644491, ECO:0000269|PubMed:29606353, ECO:0000269|PubMed:39423807, ECO:0000269|PubMed:39607926, ECO:0000303|PubMed:26375765, ECO:0000303|PubMed:27453576}. |
Q9H7U1 | CCSER2 | S630 | ochoa | Serine-rich coiled-coil domain-containing protein 2 (Coiled-coil serine-rich protein 2) (Protein GCAP14 homolog) | Microtubule-binding protein which might play a role in microtubule bundling. {ECO:0000250|UniProtKB:Q3UHI0}. |
Q9NQA5 | TRPV5 | S299 | psp | Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transport protein 2) (CaT2) (Epithelial calcium channel 1) (ECaC) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3) | Constitutively active calcium selective cation channel thought to be involved in Ca(2+) reabsorption in kidney and intestine (PubMed:11549322, PubMed:18768590). Required for normal Ca(2+) reabsorption in the kidney distal convoluted tubules (By similarity). The channel is activated by low internal calcium level and the current exhibits an inward rectification (PubMed:11549322, PubMed:18768590). A Ca(2+)-dependent feedback regulation includes fast channel inactivation and slow current decay (By similarity). Heteromeric assembly with TRPV6 seems to modify channel properties. TRPV5-TRPV6 heteromultimeric concatemers exhibit voltage-dependent gating (By similarity). {ECO:0000250|UniProtKB:P69744, ECO:0000250|UniProtKB:Q9XSM3, ECO:0000269|PubMed:11549322, ECO:0000269|PubMed:18768590}. |
Q9NW08 | POLR3B | S680 | ochoa | DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B) | Catalytic core component of RNA polymerase III (Pol III), a DNA-dependent RNA polymerase which synthesizes small non-coding RNAs using the four ribonucleoside triphosphates as substrates. Synthesizes 5S rRNA, snRNAs, tRNAs and miRNAs from at least 500 distinct genomic loci (PubMed:20413673, PubMed:33558766). Pol III-mediated transcription cycle proceeds through transcription initiation, transcription elongation and transcription termination stages. During transcription initiation, Pol III is recruited to DNA promoters type I, II or III with the help of general transcription factors and other specific initiation factors. Once the polymerase has escaped from the promoter it enters the elongation phase during which RNA is actively polymerized, based on complementarity with the template DNA strand. Transcription termination involves the release of the RNA transcript and polymerase from the DNA (PubMed:20413673, PubMed:33335104, PubMed:33558764, PubMed:33558766, PubMed:33674783, PubMed:34675218). Forms Pol III active center together with the largest subunit POLR3A/RPC1. A single-stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol III. Appends one nucleotide at a time to the 3' end of the nascent RNA, with POLR3A/RPC1 contributing a Mg(2+)-coordinating DxDGD motif, and POLR3B/RPC2 participating in the coordination of a second Mg(2+) ion and providing lysine residues believed to facilitate Watson-Crick base pairing between the incoming nucleotide and template base. Typically, Mg(2+) ions direct a 5' nucleoside triphosphate to form a phosphodiester bond with the 3' hydroxyl of the preceding nucleotide of the nascent RNA, with the elimination of pyrophosphate (PubMed:19609254, PubMed:20413673, PubMed:33335104, PubMed:33558764, PubMed:33674783, PubMed:34675218). Pol III plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as a nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF-kappa-B through the RIG-I pathway. {ECO:0000250, ECO:0000269|PubMed:19609254, ECO:0000269|PubMed:19631370, ECO:0000269|PubMed:20413673, ECO:0000269|PubMed:33335104, ECO:0000269|PubMed:33558764, ECO:0000269|PubMed:33558766, ECO:0000269|PubMed:33674783, ECO:0000269|PubMed:34675218}. |
Q9NX74 | DUS2 | S445 | ochoa | tRNA-dihydrouridine(20) synthase [NAD(P)+]-like (EC 1.3.1.91) (Dihydrouridine synthase 2) (Up-regulated in lung cancer protein 8) (URLC8) (tRNA-dihydrouridine synthase 2-like) (hDUS2) | Catalyzes the NADPH-dependent synthesis of dihydrouridine, a modified base found in the D-loop of most tRNAs (PubMed:15994936, PubMed:26429968, PubMed:30149704, PubMed:34798057, PubMed:38680565). Specifically modifies U20 in cytoplasmic tRNAs (PubMed:38680565). Activity depends on the presence of guanosine at position 19 in the tRNA substrate (PubMed:38680565). Negatively regulates the activation of EIF2AK2/PKR (PubMed:18096616). {ECO:0000269|PubMed:15994936, ECO:0000269|PubMed:18096616, ECO:0000269|PubMed:26429968, ECO:0000269|PubMed:30149704, ECO:0000269|PubMed:34798057, ECO:0000269|PubMed:38680565}. |
Q9UBY9 | HSPB7 | S54 | ochoa | Heat shock protein beta-7 (HspB7) (Cardiovascular heat shock protein) (cvHsp) | None |
Q9UHI6 | DDX20 | S187 | ochoa | Probable ATP-dependent RNA helicase DDX20 (EC 3.6.1.15) (EC 3.6.4.13) (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3) | The SMN complex catalyzes the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome, and thereby plays an important role in the splicing of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP (Sm core). In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP. To assemble core snRNPs, the SMN complex accepts the trapped 5Sm proteins from CLNS1A forming an intermediate. Binding of snRNA inside 5Sm triggers eviction of the SMN complex, thereby allowing binding of SNRPD3 and SNRPB to complete assembly of the core snRNP. May also play a role in the metabolism of small nucleolar ribonucleoprotein (snoRNPs). {ECO:0000269|PubMed:18984161}. |
Q9UKE5 | TNIK | S938 | ochoa | TRAF2 and NCK-interacting protein kinase (EC 2.7.11.1) | Serine/threonine kinase that acts as an essential activator of the Wnt signaling pathway. Recruited to promoters of Wnt target genes and required to activate their expression. May act by phosphorylating TCF4/TCF7L2. Appears to act upstream of the JUN N-terminal pathway. May play a role in the response to environmental stress. Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development. More generally, it may play a role in cytoskeletal rearrangements and regulate cell spreading. Phosphorylates SMAD1 on Thr-322. Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000269|PubMed:10521462, ECO:0000269|PubMed:15342639, ECO:0000269|PubMed:19061864, ECO:0000269|PubMed:19816403, ECO:0000269|PubMed:20159449, ECO:0000269|PubMed:21690388, ECO:0000269|PubMed:26437443}. |
Q9UKJ3 | GPATCH8 | S352 | ochoa | G patch domain-containing protein 8 | None |
Q9ULI3 | HEG1 | S1332 | ochoa | Protein HEG homolog 1 | Receptor component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions. {ECO:0000250}. |
Q9UPQ3 | AGAP1 | S101 | ochoa | Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 (AGAP-1) (Centaurin-gamma-2) (Cnt-g2) (GTP-binding and GTPase-activating protein 1) (GGAP1) | GTPase-activating protein for ARF1 and, to a lesser extent, ARF5. Directly and specifically regulates the adapter protein 3 (AP-3)-dependent trafficking of proteins in the endosomal-lysosomal system. {ECO:0000269|PubMed:12640130}. |
Q9Y2H9 | MAST1 | S139 | ochoa | Microtubule-associated serine/threonine-protein kinase 1 (EC 2.7.11.1) (Syntrophin-associated serine/threonine-protein kinase) | Microtubule-associated protein essential for correct brain development (PubMed:30449657). Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins (By similarity). {ECO:0000250|UniProtKB:Q9R1L5, ECO:0000269|PubMed:30449657}. |
Q9Y2L6 | FRMD4B | S915 | ochoa | FERM domain-containing protein 4B (GRP1-binding protein GRSP1) | Member of GRP1 signaling complexes that are acutely recruited to plasma membrane ruffles in response to insulin receptor signaling. May function as a scaffolding protein that regulates epithelial cell polarity by connecting ARF6 activation with the PAR3 complex. Plays a redundant role with FRMD4A in epithelial polarization. {ECO:0000250|UniProtKB:Q920B0}. |
Q9Y320 | TMX2 | S211 | ochoa | Thioredoxin-related transmembrane protein 2 (Cell proliferation-inducing gene 26 protein) (Thioredoxin domain-containing protein 14) | Endoplasmic reticulum and mitochondria-associated protein that probably functions as a regulator of cellular redox state and thereby regulates protein post-translational modification, protein folding and mitochondrial activity. Indirectly regulates neuronal proliferation, migration, and organization in the developing brain. {ECO:0000269|PubMed:31735293}. |
Q9Y4G2 | PLEKHM1 | S432 | ochoa | Pleckstrin homology domain-containing family M member 1 (PH domain-containing family M member 1) (162 kDa adapter protein) (AP162) | Acts as a multivalent adapter protein that regulates Rab7-dependent and HOPS complex-dependent fusion events in the endolysosomal system and couples autophagic and the endocytic trafficking pathways. Acts as a dual effector of RAB7A and ARL8B that simultaneously binds these GTPases, bringing about clustering and fusion of late endosomes and lysosomes (PubMed:25498145, PubMed:28325809). Required for late stages of endolysosomal maturation, facilitating both endocytosis-mediated degradation of growth factor receptors and autophagosome clearance. Interaction with Arl8b is a crucial factor in the terminal maturation of autophagosomes and to mediate autophagosome-lysosome fusion (PubMed:25498145). Positively regulates lysosome peripheral distribution and ruffled border formation in osteoclasts (By similarity). May be involved in negative regulation of endocytic transport from early endosome to late endosome/lysosome implicating its association with Rab7 (PubMed:20943950). May have a role in sialyl-lex-mediated transduction of apoptotic signals (PubMed:12820725). Involved in bone resorption (By similarity). {ECO:0000250|UniProtKB:Q5PQS0, ECO:0000250|UniProtKB:Q7TSI1, ECO:0000269|PubMed:12820725, ECO:0000269|PubMed:20943950, ECO:0000269|PubMed:25498145, ECO:0000269|PubMed:28325809}.; FUNCTION: (Microbial infection) In case of infection contributes to Salmonella typhimurium pathogenesis by supporting the integrity of the Salmonella-containing vacuole (SCV) probably in concert with the HOPS complex and Rab7. {ECO:0000269|PubMed:25500191}. |
Q9Y5I7 | CLDN16 | S147 | psp | Claudin-16 (Paracellin-1) (PCLN-1) | Forms paracellular channels: coassembles with CLDN19 into tight junction strands with cation-selective channels through the strands, conveying epithelial permeability in a process known as paracellular tight junction permeability (PubMed:16234325, PubMed:18188451, PubMed:28028216). Involved in the maintenance of ion gradients along the nephron. In the thick ascending limb (TAL) of Henle's loop, facilitates sodium paracellular permeability from the interstitial compartment to the lumen, contributing to the lumen-positive transepithelial potential that drives paracellular magnesium and calcium reabsorption (PubMed:10390358, PubMed:11518780, PubMed:14628289, PubMed:16528408, PubMed:28028216). {ECO:0000269|PubMed:10390358, ECO:0000269|PubMed:11518780, ECO:0000269|PubMed:14628289, ECO:0000269|PubMed:16234325, ECO:0000269|PubMed:16528408, ECO:0000269|PubMed:18188451, ECO:0000269|PubMed:28028216}. |
P13667 | PDIA4 | Y137 | Sugiyama | Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72) | None |
Q5R3I4 | TTC38 | S362 | Sugiyama | Tetratricopeptide repeat protein 38 (TPR repeat protein 38) | None |
P13667 | PDIA4 | Y252 | Sugiyama | Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72) | None |
Q8NBS9 | TXNDC5 | Y262 | Sugiyama | Thioredoxin domain-containing protein 5 (EC 1.8.4.-) (EC 5.3.4.1) (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46) | Protein disulfide isomerase of the endoplasmic reticulum lumen involved in the formation of disulfide bonds in proteins. Can reduce insulin disulfide bonds. {ECO:0000250|UniProtKB:Q91W90}. |
Q6UVK1 | CSPG4 | S1609 | Sugiyama | Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (Melanoma chondroitin sulfate proteoglycan) (Melanoma-associated chondroitin sulfate proteoglycan) | Proteoglycan playing a role in cell proliferation and migration which stimulates endothelial cells motility during microvascular morphogenesis. May also inhibit neurite outgrowth and growth cone collapse during axon regeneration. Cell surface receptor for collagen alpha 2(VI) which may confer cells ability to migrate on that substrate. Binds through its extracellular N-terminus growth factors, extracellular matrix proteases modulating their activity. May regulate MPP16-dependent degradation and invasion of type I collagen participating in melanoma cells invasion properties. May modulate the plasminogen system by enhancing plasminogen activation and inhibiting angiostatin. Also functions as a signal transducing protein by binding through its cytoplasmic C-terminus scaffolding and signaling proteins. May promote retraction fiber formation and cell polarization through Rho GTPase activation. May stimulate alpha-4, beta-1 integrin-mediated adhesion and spreading by recruiting and activating a signaling cascade through CDC42, ACK1 and BCAR1. May activate FAK and ERK1/ERK2 signaling cascades. {ECO:0000269|PubMed:10587647, ECO:0000269|PubMed:11278606, ECO:0000269|PubMed:15210734}. |
P10636 | MAPT | S641 | SIGNOR|EPSD | Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) | Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed:21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed:21985311, PubMed:32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization. {ECO:0000269|PubMed:21985311, ECO:0000269|PubMed:32961270}. |
Q8IU85 | CAMK1D | S159 | Sugiyama | Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK) | Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, activates CREB-dependent gene transcription, regulates calcium-mediated granulocyte function and respiratory burst and promotes basal dendritic growth of hippocampal neurons. In neutrophil cells, required for cytokine-induced proliferative responses and activation of the respiratory burst. Activates the transcription factor CREB1 in hippocampal neuron nuclei. May play a role in apoptosis of erythroleukemia cells. In vitro, phosphorylates transcription factor CREM isoform Beta. {ECO:0000269|PubMed:11050006, ECO:0000269|PubMed:15840691, ECO:0000269|PubMed:16324104, ECO:0000269|PubMed:17056143}. |
P10636 | MAPT | S610 | GPS6|EPSD | Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) | Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed:21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed:21985311, PubMed:32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization. {ECO:0000269|PubMed:21985311, ECO:0000269|PubMed:32961270}. |
O95255 | ABCC6 | S66 | Sugiyama | ATP-binding cassette sub-family C member 6 (EC 7.6.2.-) (EC 7.6.2.3) (Anthracycline resistance-associated protein) (Multi-specific organic anion transporter E) (MOAT-E) (Multidrug resistance-associated protein 6) | [Isoform 1]: ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds, and xenobiotics from cells. Mediates ATP-dependent transport of glutathione conjugates such as leukotriene-c4 (LTC4) and N-ethylmaleimide S-glutathione (NEM-GS) (in vitro), and an anionic cyclopentapeptide endothelin antagonist, BQ-123 (PubMed:11880368, PubMed:12414644). May contribute to regulate the transport of organic compounds in testes across the blood-testis-barrier (Probable). Does not appear to actively transport drugs outside the cell. Confers low levels of cellular resistance to etoposide, teniposide, anthracyclines and cisplatin (PubMed:12414644). {ECO:0000269|PubMed:11880368, ECO:0000269|PubMed:12414644, ECO:0000305|PubMed:35307651}.; FUNCTION: [Isoform 1]: Mediates the release of nucleoside triphosphates, predominantly ATP, into the circulation, where it is rapidly converted into AMP and the mineralization inhibitor inorganic pyrophosphate (PPi) by the ecto-enzyme ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1), therefore playing a role in PPi homeostasis. {ECO:0000269|PubMed:24277820, ECO:0000269|PubMed:24969777}.; FUNCTION: [Isoform 2]: Inhibits TNF-alpha-mediated apoptosis through blocking one or more caspases. {ECO:0000269|PubMed:23912081}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-3371568 | Attenuation phase | 1.110223e-16 | 15.955 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 3.330669e-16 | 15.477 |
R-HSA-3371571 | HSF1-dependent transactivation | 8.881784e-16 | 15.051 |
R-HSA-3371556 | Cellular response to heat stress | 5.440093e-15 | 14.264 |
R-HSA-3371511 | HSF1 activation | 1.268097e-12 | 11.897 |
R-HSA-2262752 | Cellular responses to stress | 1.528806e-06 | 5.816 |
R-HSA-8953897 | Cellular responses to stimuli | 1.026255e-05 | 4.989 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 2.825560e-04 | 3.549 |
R-HSA-9833482 | PKR-mediated signaling | 4.916713e-04 | 3.308 |
R-HSA-913531 | Interferon Signaling | 7.682993e-04 | 3.114 |
R-HSA-180024 | DARPP-32 events | 2.220267e-03 | 2.654 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 2.892115e-03 | 2.539 |
R-HSA-2025928 | Calcineurin activates NFAT | 3.559858e-03 | 2.449 |
R-HSA-9725554 | Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | 4.758089e-03 | 2.323 |
R-HSA-163765 | ChREBP activates metabolic gene expression | 4.799772e-03 | 2.319 |
R-HSA-381183 | ATF6 (ATF6-alpha) activates chaperone genes | 5.483981e-03 | 2.261 |
R-HSA-9029558 | NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | 6.977704e-03 | 2.156 |
R-HSA-381033 | ATF6 (ATF6-alpha) activates chaperones | 6.977704e-03 | 2.156 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 7.382192e-03 | 2.132 |
R-HSA-5607763 | CLEC7A (Dectin-1) induces NFAT activation | 7.785959e-03 | 2.109 |
R-HSA-8876725 | Protein methylation | 8.634314e-03 | 2.064 |
R-HSA-5690338 | Defective ABCC6 causes PXE | 2.864815e-02 | 1.543 |
R-HSA-5083630 | Defective LFNG causes SCDO3 | 4.266556e-02 | 1.370 |
R-HSA-3595172 | Defective CHST3 causes SEDCJD | 6.331649e-02 | 1.198 |
R-HSA-6802953 | RAS signaling downstream of NF1 loss-of-function variants | 6.331649e-02 | 1.198 |
R-HSA-3595174 | Defective CHST14 causes EDS, musculocontractural type | 6.331649e-02 | 1.198 |
R-HSA-1912399 | Pre-NOTCH Processing in the Endoplasmic Reticulum | 7.010150e-02 | 1.154 |
R-HSA-3595177 | Defective CHSY1 causes TPBS | 7.010150e-02 | 1.154 |
R-HSA-446107 | Type I hemidesmosome assembly | 7.683778e-02 | 1.114 |
R-HSA-450520 | HuR (ELAVL1) binds and stabilizes mRNA | 8.352567e-02 | 1.078 |
R-HSA-9613354 | Lipophagy | 8.352567e-02 | 1.078 |
R-HSA-9700645 | ALK mutants bind TKIs | 8.352567e-02 | 1.078 |
R-HSA-451308 | Activation of Ca-permeable Kainate Receptor | 9.016553e-02 | 1.045 |
R-HSA-2022923 | DS-GAG biosynthesis | 1.033025e-01 | 0.986 |
R-HSA-2197563 | NOTCH2 intracellular domain regulates transcription | 1.098003e-01 | 0.959 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 2.862297e-02 | 1.543 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 3.009455e-02 | 1.522 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 3.009455e-02 | 1.522 |
R-HSA-73780 | RNA Polymerase III Chain Elongation | 1.290148e-01 | 0.889 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 3.312580e-02 | 1.480 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 3.312580e-02 | 1.480 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 3.468450e-02 | 1.460 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 3.788559e-02 | 1.422 |
R-HSA-4420332 | Defective B3GALT6 causes EDSP2 and SEMDJL1 | 1.415955e-01 | 0.849 |
R-HSA-3560783 | Defective B4GALT7 causes EDS, progeroid type | 1.415955e-01 | 0.849 |
R-HSA-3560801 | Defective B3GAT3 causes JDSSDHD | 1.478181e-01 | 0.830 |
R-HSA-194441 | Metabolism of non-coding RNA | 1.317744e-02 | 1.880 |
R-HSA-191859 | snRNP Assembly | 1.317744e-02 | 1.880 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 4.460931e-02 | 1.351 |
R-HSA-73980 | RNA Polymerase III Transcription Termination | 1.539960e-01 | 0.812 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 4.635452e-02 | 1.334 |
R-HSA-1912420 | Pre-NOTCH Processing in Golgi | 1.601295e-01 | 0.796 |
R-HSA-9934037 | Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | 1.662188e-01 | 0.779 |
R-HSA-2022870 | CS-GAG biosynthesis | 1.782666e-01 | 0.749 |
R-HSA-438066 | Unblocking of NMDA receptors, glutamate binding and activation | 1.782666e-01 | 0.749 |
R-HSA-442982 | Ras activation upon Ca2+ influx through NMDA receptor | 1.782666e-01 | 0.749 |
R-HSA-72649 | Translation initiation complex formation | 7.527022e-02 | 1.123 |
R-HSA-141424 | Amplification of signal from the kinetochores | 3.164890e-02 | 1.500 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 3.164890e-02 | 1.500 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 7.947176e-02 | 1.100 |
R-HSA-9954714 | PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 1.647912e-01 | 0.783 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 1.673517e-01 | 0.776 |
R-HSA-9954716 | ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ri... | 1.776607e-01 | 0.750 |
R-HSA-72689 | Formation of a pool of free 40S subunits | 1.802537e-01 | 0.744 |
R-HSA-192823 | Viral mRNA Translation | 2.011891e-01 | 0.696 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 2.144159e-01 | 0.669 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 2.170716e-01 | 0.663 |
R-HSA-1980145 | Signaling by NOTCH2 | 3.627125e-02 | 1.440 |
R-HSA-2979096 | NOTCH2 Activation and Transmission of Signal to the Nucleus | 1.564497e-02 | 1.806 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 1.396229e-01 | 0.855 |
R-HSA-156902 | Peptide chain elongation | 1.571541e-01 | 0.804 |
R-HSA-5205685 | PINK1-PRKN Mediated Mitophagy | 2.190904e-01 | 0.659 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 1.177965e-01 | 0.929 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 1.591789e-01 | 0.798 |
R-HSA-9619483 | Activation of AMPK downstream of NMDARs | 2.190904e-01 | 0.659 |
R-HSA-9930044 | Nuclear RNA decay | 3.312580e-02 | 1.480 |
R-HSA-72764 | Eukaryotic Translation Termination | 1.802537e-01 | 0.744 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 4.776070e-02 | 1.321 |
R-HSA-9017802 | Noncanonical activation of NOTCH3 | 5.648240e-02 | 1.248 |
R-HSA-176974 | Unwinding of DNA | 8.352567e-02 | 1.078 |
R-HSA-451306 | Ionotropic activity of kainate receptors | 9.675769e-02 | 1.014 |
R-HSA-5658623 | FGFRL1 modulation of FGFR1 signaling | 9.675769e-02 | 1.014 |
R-HSA-432720 | Lysosome Vesicle Biogenesis | 3.952703e-02 | 1.403 |
R-HSA-450408 | AUF1 (hnRNP D0) binds and destabilizes mRNA | 3.952703e-02 | 1.403 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 4.119510e-02 | 1.385 |
R-HSA-181429 | Serotonin Neurotransmitter Release Cycle | 1.539960e-01 | 0.812 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 5.733144e-02 | 1.242 |
R-HSA-76066 | RNA Polymerase III Transcription Initiation From Type 2 Promoter | 1.782666e-01 | 0.749 |
R-HSA-76071 | RNA Polymerase III Transcription Initiation From Type 3 Promoter | 1.842256e-01 | 0.735 |
R-HSA-350054 | Notch-HLH transcription pathway | 1.842256e-01 | 0.735 |
R-HSA-9613829 | Chaperone Mediated Autophagy | 1.539960e-01 | 0.812 |
R-HSA-6794361 | Neurexins and neuroligins | 7.114331e-02 | 1.148 |
R-HSA-156842 | Eukaryotic Translation Elongation | 1.699191e-01 | 0.770 |
R-HSA-9620244 | Long-term potentiation | 2.018467e-01 | 0.695 |
R-HSA-8963888 | Chylomicron assembly | 9.675769e-02 | 1.014 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 3.468450e-02 | 1.460 |
R-HSA-212676 | Dopamine Neurotransmitter Release Cycle | 1.842256e-01 | 0.735 |
R-HSA-76061 | RNA Polymerase III Transcription Initiation From Type 1 Promoter | 1.842256e-01 | 0.735 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 1.913457e-01 | 0.718 |
R-HSA-6798695 | Neutrophil degranulation | 1.358107e-01 | 0.867 |
R-HSA-6794362 | Protein-protein interactions at synapses | 3.080769e-02 | 1.511 |
R-HSA-8849932 | Synaptic adhesion-like molecules | 1.539960e-01 | 0.812 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 1.835577e-02 | 1.736 |
R-HSA-8964041 | LDL remodeling | 7.010150e-02 | 1.154 |
R-HSA-9839383 | TGFBR3 PTM regulation | 7.683778e-02 | 1.114 |
R-HSA-168330 | Viral RNP Complexes in the Host Cell Nucleus | 1.033025e-01 | 0.986 |
R-HSA-9735869 | SARS-CoV-1 modulates host translation machinery | 3.627125e-02 | 1.440 |
R-HSA-9754678 | SARS-CoV-2 modulates host translation machinery | 1.071700e-02 | 1.970 |
R-HSA-429958 | mRNA decay by 3' to 5' exoribonuclease | 1.601295e-01 | 0.796 |
R-HSA-264642 | Acetylcholine Neurotransmitter Release Cycle | 1.722645e-01 | 0.764 |
R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex | 5.924117e-02 | 1.227 |
R-HSA-181430 | Norepinephrine Neurotransmitter Release Cycle | 1.960153e-01 | 0.708 |
R-HSA-420029 | Tight junction interactions | 2.018467e-01 | 0.695 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and sub... | 8.374497e-02 | 1.077 |
R-HSA-451326 | Activation of kainate receptors upon glutamate binding | 2.190904e-01 | 0.659 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 9.028283e-02 | 1.044 |
R-HSA-6809371 | Formation of the cornified envelope | 7.999883e-02 | 1.097 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 2.170716e-01 | 0.663 |
R-HSA-112310 | Neurotransmitter release cycle | 1.622380e-01 | 0.790 |
R-HSA-68877 | Mitotic Prometaphase | 2.005621e-01 | 0.698 |
R-HSA-199992 | trans-Golgi Network Vesicle Budding | 1.154289e-01 | 0.938 |
R-HSA-204005 | COPII-mediated vesicle transport | 1.107315e-01 | 0.956 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 7.604057e-02 | 1.119 |
R-HSA-9663891 | Selective autophagy | 1.571541e-01 | 0.804 |
R-HSA-180746 | Nuclear import of Rev protein | 3.627125e-02 | 1.440 |
R-HSA-432722 | Golgi Associated Vesicle Biogenesis | 7.319725e-02 | 1.136 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 3.803596e-02 | 1.420 |
R-HSA-2408557 | Selenocysteine synthesis | 1.959262e-01 | 0.708 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 6.350709e-02 | 1.197 |
R-HSA-8953854 | Metabolism of RNA | 4.751333e-02 | 1.323 |
R-HSA-447038 | NrCAM interactions | 4.959887e-02 | 1.305 |
R-HSA-428890 | Role of ABL in ROBO-SLIT signaling | 7.010150e-02 | 1.154 |
R-HSA-450513 | Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 1.290148e-01 | 0.889 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 4.635452e-02 | 1.334 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 4.635452e-02 | 1.334 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 4.812455e-02 | 1.318 |
R-HSA-9617324 | Negative regulation of NMDA receptor-mediated neuronal transmission | 1.782666e-01 | 0.749 |
R-HSA-210500 | Glutamate Neurotransmitter Release Cycle | 2.076361e-01 | 0.683 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 2.038269e-01 | 0.691 |
R-HSA-2467813 | Separation of Sister Chromatids | 1.471647e-01 | 0.832 |
R-HSA-157118 | Signaling by NOTCH | 1.218926e-01 | 0.914 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 1.985555e-01 | 0.702 |
R-HSA-389977 | Post-chaperonin tubulin folding pathway | 1.662188e-01 | 0.779 |
R-HSA-199991 | Membrane Trafficking | 2.142697e-01 | 0.669 |
R-HSA-8874177 | ATF6B (ATF6-beta) activates chaperones | 2.864815e-02 | 1.543 |
R-HSA-8866423 | VLDL assembly | 6.331649e-02 | 1.198 |
R-HSA-447041 | CHL1 interactions | 7.010150e-02 | 1.154 |
R-HSA-9013700 | NOTCH4 Activation and Transmission of Signal to the Nucleus | 8.352567e-02 | 1.078 |
R-HSA-193692 | Regulated proteolysis of p75NTR | 8.352567e-02 | 1.078 |
R-HSA-5682910 | LGI-ADAM interactions | 9.675769e-02 | 1.014 |
R-HSA-111447 | Activation of BAD and translocation to mitochondria | 1.290148e-01 | 0.889 |
R-HSA-9933946 | Formation of the embryonic stem cell BAF (esBAF) complex | 1.290148e-01 | 0.889 |
R-HSA-450604 | KSRP (KHSRP) binds and destabilizes mRNA | 1.353278e-01 | 0.869 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 4.288935e-02 | 1.368 |
R-HSA-9615933 | Postmitotic nuclear pore complex (NPC) reformation | 2.076361e-01 | 0.683 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 1.154289e-01 | 0.938 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 5.878836e-02 | 1.231 |
R-HSA-381042 | PERK regulates gene expression | 3.788559e-02 | 1.422 |
R-HSA-438064 | Post NMDA receptor activation events | 1.546238e-01 | 0.811 |
R-HSA-73621 | Pyrimidine catabolism | 5.357906e-02 | 1.271 |
R-HSA-162658 | Golgi Cisternae Pericentriolar Stack Reorganization | 1.162514e-01 | 0.935 |
R-HSA-450385 | Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 1.290148e-01 | 0.889 |
R-HSA-388844 | Receptor-type tyrosine-protein phosphatases | 1.353278e-01 | 0.869 |
R-HSA-9909505 | Modulation of host responses by IFN-stimulated genes | 1.478181e-01 | 0.830 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 4.460931e-02 | 1.351 |
R-HSA-75105 | Fatty acyl-CoA biosynthesis | 1.107315e-01 | 0.956 |
R-HSA-8963898 | Plasma lipoprotein assembly | 1.960153e-01 | 0.708 |
R-HSA-68886 | M Phase | 1.705534e-01 | 0.768 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 8.159959e-02 | 1.088 |
R-HSA-9932451 | SWI/SNF chromatin remodelers | 2.018467e-01 | 0.695 |
R-HSA-9932444 | ATP-dependent chromatin remodelers | 2.018467e-01 | 0.695 |
R-HSA-9010642 | ROBO receptors bind AKAP5 | 7.683778e-02 | 1.114 |
R-HSA-9828642 | Respiratory syncytial virus genome transcription | 1.226561e-01 | 0.911 |
R-HSA-205043 | NRIF signals cell death from the nucleus | 1.226561e-01 | 0.911 |
R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus | 2.076361e-01 | 0.683 |
R-HSA-3295583 | TRP channels | 2.076361e-01 | 0.683 |
R-HSA-380994 | ATF4 activates genes in response to endoplasmic reticulum stress | 2.190904e-01 | 0.659 |
R-HSA-6784531 | tRNA processing in the nucleus | 9.249486e-02 | 1.034 |
R-HSA-168255 | Influenza Infection | 1.516643e-02 | 1.819 |
R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | 1.842256e-01 | 0.735 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 1.107315e-01 | 0.956 |
R-HSA-68882 | Mitotic Anaphase | 9.396095e-02 | 1.027 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 9.505708e-02 | 1.022 |
R-HSA-264876 | Insulin processing | 2.133839e-01 | 0.671 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 1.177965e-01 | 0.929 |
R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription | 1.722645e-01 | 0.764 |
R-HSA-4086398 | Ca2+ pathway | 1.177965e-01 | 0.929 |
R-HSA-9827857 | Specification of primordial germ cells | 1.141389e-02 | 1.943 |
R-HSA-264870 | Caspase-mediated cleavage of cytoskeletal proteins | 8.352567e-02 | 1.078 |
R-HSA-8949215 | Mitochondrial calcium ion transport | 1.679262e-02 | 1.775 |
R-HSA-193048 | Androgen biosynthesis | 1.782666e-01 | 0.749 |
R-HSA-73614 | Pyrimidine salvage | 2.190904e-01 | 0.659 |
R-HSA-9013694 | Signaling by NOTCH4 | 1.201765e-01 | 0.920 |
R-HSA-69620 | Cell Cycle Checkpoints | 1.449135e-01 | 0.839 |
R-HSA-68875 | Mitotic Prophase | 7.474109e-02 | 1.126 |
R-HSA-70171 | Glycolysis | 1.933015e-01 | 0.714 |
R-HSA-9020933 | Interleukin-23 signaling | 7.683778e-02 | 1.114 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 5.763573e-02 | 1.239 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 3.694715e-02 | 1.432 |
R-HSA-3000170 | Syndecan interactions | 1.901417e-01 | 0.721 |
R-HSA-3000157 | Laminin interactions | 2.018467e-01 | 0.695 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 1.828525e-01 | 0.738 |
R-HSA-376176 | Signaling by ROBO receptors | 7.926769e-02 | 1.101 |
R-HSA-1169408 | ISG15 antiviral mechanism | 1.225684e-01 | 0.912 |
R-HSA-2672351 | Stimuli-sensing channels | 2.170716e-01 | 0.663 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 1.225684e-01 | 0.912 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 1.055354e-01 | 0.977 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 1.906816e-01 | 0.720 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 3.531101e-02 | 1.452 |
R-HSA-1474290 | Collagen formation | 1.750738e-01 | 0.757 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 1.985555e-01 | 0.702 |
R-HSA-9841251 | Mitochondrial unfolded protein response (UPRmt) | 2.439050e-02 | 1.613 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 9.472267e-02 | 1.024 |
R-HSA-9700206 | Signaling by ALK in cancer | 2.144159e-01 | 0.669 |
R-HSA-1236394 | Signaling by ERBB4 | 1.201765e-01 | 0.920 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 1.322500e-01 | 0.879 |
R-HSA-72306 | tRNA processing | 1.591789e-01 | 0.798 |
R-HSA-111885 | Opioid Signalling | 5.203776e-02 | 1.284 |
R-HSA-9024446 | NR1H2 and NR1H3-mediated signaling | 1.273870e-01 | 0.895 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 2.144159e-01 | 0.669 |
R-HSA-211000 | Gene Silencing by RNA | 2.144159e-01 | 0.669 |
R-HSA-422475 | Axon guidance | 1.189718e-01 | 0.925 |
R-HSA-9675108 | Nervous system development | 1.502055e-01 | 0.823 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 2.117634e-01 | 0.674 |
R-HSA-9694516 | SARS-CoV-2 Infection | 1.320148e-01 | 0.879 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 1.011314e-01 | 0.995 |
R-HSA-9615710 | Late endosomal microautophagy | 2.247558e-01 | 0.648 |
R-HSA-6805567 | Keratinization | 2.268965e-01 | 0.644 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 2.277229e-01 | 0.643 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 2.277229e-01 | 0.643 |
R-HSA-1483249 | Inositol phosphate metabolism | 2.277229e-01 | 0.643 |
R-HSA-68962 | Activation of the pre-replicative complex | 2.303805e-01 | 0.638 |
R-HSA-76046 | RNA Polymerase III Transcription Initiation | 2.303805e-01 | 0.638 |
R-HSA-888590 | GABA synthesis, release, reuptake and degradation | 2.303805e-01 | 0.638 |
R-HSA-114452 | Activation of BH3-only proteins | 2.303805e-01 | 0.638 |
R-HSA-399719 | Trafficking of AMPA receptors | 2.359646e-01 | 0.627 |
R-HSA-112315 | Transmission across Chemical Synapses | 2.395631e-01 | 0.621 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 2.410880e-01 | 0.618 |
R-HSA-69190 | DNA strand elongation | 2.415087e-01 | 0.617 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 2.415087e-01 | 0.617 |
R-HSA-72737 | Cap-dependent Translation Initiation | 2.437661e-01 | 0.613 |
R-HSA-72613 | Eukaryotic Translation Initiation | 2.437661e-01 | 0.613 |
R-HSA-373760 | L1CAM interactions | 2.437661e-01 | 0.613 |
R-HSA-70326 | Glucose metabolism | 2.464455e-01 | 0.608 |
R-HSA-442742 | CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 2.470128e-01 | 0.607 |
R-HSA-176187 | Activation of ATR in response to replication stress | 2.470128e-01 | 0.607 |
R-HSA-399721 | Glutamate binding, activation of AMPA receptors and synaptic plasticity | 2.470128e-01 | 0.607 |
R-HSA-2024101 | CS/DS degradation | 2.524773e-01 | 0.598 |
R-HSA-199220 | Vitamin B5 (pantothenate) metabolism | 2.524773e-01 | 0.598 |
R-HSA-69278 | Cell Cycle, Mitotic | 2.552364e-01 | 0.593 |
R-HSA-1971475 | Glycosaminoglycan-protein linkage region biosynthesis | 2.579025e-01 | 0.589 |
R-HSA-5205647 | Mitophagy | 2.579025e-01 | 0.589 |
R-HSA-983170 | Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 2.579025e-01 | 0.589 |
R-HSA-162909 | Host Interactions of HIV factors | 2.652254e-01 | 0.576 |
R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation | 2.686361e-01 | 0.571 |
R-HSA-74158 | RNA Polymerase III Transcription | 2.686361e-01 | 0.571 |
R-HSA-72312 | rRNA processing | 2.773182e-01 | 0.557 |
R-HSA-8956319 | Nucleotide catabolism | 2.813292e-01 | 0.551 |
R-HSA-112316 | Neuronal System | 2.832494e-01 | 0.548 |
R-HSA-9820965 | Respiratory syncytial virus (RSV) genome replication, transcription and translat... | 2.844485e-01 | 0.546 |
R-HSA-1474165 | Reproduction | 2.866929e-01 | 0.543 |
R-HSA-1251985 | Nuclear signaling by ERBB4 | 2.896436e-01 | 0.538 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 2.948013e-01 | 0.530 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 2.999219e-01 | 0.523 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 3.054293e-01 | 0.515 |
R-HSA-163685 | Integration of energy metabolism | 3.054293e-01 | 0.515 |
R-HSA-5619115 | Disorders of transmembrane transporters | 3.069317e-01 | 0.513 |
R-HSA-75876 | Synthesis of very long-chain fatty acyl-CoAs | 3.100527e-01 | 0.509 |
R-HSA-9948299 | Ribosome-associated quality control | 3.107681e-01 | 0.508 |
R-HSA-3214858 | RMTs methylate histone arginines | 3.150635e-01 | 0.502 |
R-HSA-1632852 | Macroautophagy | 3.187608e-01 | 0.497 |
R-HSA-3560782 | Diseases associated with glycosaminoglycan metabolism | 3.200382e-01 | 0.495 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 3.240778e-01 | 0.489 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 3.240778e-01 | 0.489 |
R-HSA-9839373 | Signaling by TGFBR3 | 3.249770e-01 | 0.488 |
R-HSA-75153 | Apoptotic execution phase | 3.249770e-01 | 0.488 |
R-HSA-3928665 | EPH-ephrin mediated repulsion of cells | 3.298803e-01 | 0.482 |
R-HSA-8963899 | Plasma lipoprotein remodeling | 3.347483e-01 | 0.475 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 3.373236e-01 | 0.472 |
R-HSA-9734767 | Developmental Cell Lineages | 3.386600e-01 | 0.470 |
R-HSA-5658442 | Regulation of RAS by GAPs | 3.443793e-01 | 0.463 |
R-HSA-5358346 | Hedgehog ligand biogenesis | 3.491429e-01 | 0.457 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 3.504932e-01 | 0.455 |
R-HSA-68949 | Orc1 removal from chromatin | 3.538721e-01 | 0.451 |
R-HSA-73887 | Death Receptor Signaling | 3.557371e-01 | 0.449 |
R-HSA-9612973 | Autophagy | 3.609664e-01 | 0.443 |
R-HSA-9610379 | HCMV Late Events | 3.635753e-01 | 0.439 |
R-HSA-162587 | HIV Life Cycle | 3.635753e-01 | 0.439 |
R-HSA-9711097 | Cellular response to starvation | 3.661802e-01 | 0.436 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 3.661802e-01 | 0.436 |
R-HSA-1793185 | Chondroitin sulfate/dermatan sulfate metabolism | 3.678563e-01 | 0.434 |
R-HSA-9012852 | Signaling by NOTCH3 | 3.678563e-01 | 0.434 |
R-HSA-877300 | Interferon gamma signaling | 3.687812e-01 | 0.433 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 3.703197e-01 | 0.431 |
R-HSA-193648 | NRAGE signals death through JNK | 3.724507e-01 | 0.429 |
R-HSA-5578775 | Ion homeostasis | 3.724507e-01 | 0.429 |
R-HSA-3299685 | Detoxification of Reactive Oxygen Species | 3.724507e-01 | 0.429 |
R-HSA-5654736 | Signaling by FGFR1 | 3.724507e-01 | 0.429 |
R-HSA-109606 | Intrinsic Pathway for Apoptosis | 3.724507e-01 | 0.429 |
R-HSA-109581 | Apoptosis | 3.765592e-01 | 0.424 |
R-HSA-2408522 | Selenoamino acid metabolism | 3.817232e-01 | 0.418 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 3.860362e-01 | 0.413 |
R-HSA-2022090 | Assembly of collagen fibrils and other multimeric structures | 3.860362e-01 | 0.413 |
R-HSA-5619102 | SLC transporter disorders | 3.894355e-01 | 0.410 |
R-HSA-983189 | Kinesins | 3.904995e-01 | 0.408 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 3.904995e-01 | 0.408 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 3.904995e-01 | 0.408 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 3.904995e-01 | 0.408 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 3.904995e-01 | 0.408 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 3.904995e-01 | 0.408 |
R-HSA-8956321 | Nucleotide salvage | 3.949307e-01 | 0.403 |
R-HSA-5653656 | Vesicle-mediated transport | 3.975006e-01 | 0.401 |
R-HSA-1268020 | Mitochondrial protein import | 3.993300e-01 | 0.399 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 4.021953e-01 | 0.396 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 4.036975e-01 | 0.394 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 4.036975e-01 | 0.394 |
R-HSA-6790901 | rRNA modification in the nucleus and cytosol | 4.036975e-01 | 0.394 |
R-HSA-5689880 | Ub-specific processing proteases | 4.072647e-01 | 0.390 |
R-HSA-9679506 | SARS-CoV Infections | 4.079081e-01 | 0.389 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 4.123137e-01 | 0.385 |
R-HSA-9678108 | SARS-CoV-1 Infection | 4.123137e-01 | 0.385 |
R-HSA-8854518 | AURKA Activation by TPX2 | 4.166121e-01 | 0.380 |
R-HSA-6782315 | tRNA modification in the nucleus and cytosol | 4.166121e-01 | 0.380 |
R-HSA-196071 | Metabolism of steroid hormones | 4.208550e-01 | 0.376 |
R-HSA-2559583 | Cellular Senescence | 4.248438e-01 | 0.372 |
R-HSA-1650814 | Collagen biosynthesis and modifying enzymes | 4.250674e-01 | 0.372 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 4.334011e-01 | 0.363 |
R-HSA-3781865 | Diseases of glycosylation | 4.347692e-01 | 0.362 |
R-HSA-1640170 | Cell Cycle | 4.371350e-01 | 0.359 |
R-HSA-3906995 | Diseases associated with O-glycosylation of proteins | 4.375230e-01 | 0.359 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 4.456777e-01 | 0.351 |
R-HSA-69052 | Switching of origins to a post-replicative state | 4.456777e-01 | 0.351 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 4.456777e-01 | 0.351 |
R-HSA-983712 | Ion channel transport | 4.470475e-01 | 0.350 |
R-HSA-380287 | Centrosome maturation | 4.537152e-01 | 0.343 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 4.543438e-01 | 0.343 |
R-HSA-8957322 | Metabolism of steroids | 4.574172e-01 | 0.340 |
R-HSA-1980143 | Signaling by NOTCH1 | 4.576905e-01 | 0.339 |
R-HSA-9020591 | Interleukin-12 signaling | 4.576905e-01 | 0.339 |
R-HSA-9609690 | HCMV Early Events | 4.639872e-01 | 0.333 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 4.655553e-01 | 0.332 |
R-HSA-416482 | G alpha (12/13) signalling events | 4.655553e-01 | 0.332 |
R-HSA-5619084 | ABC transporter disorders | 4.655553e-01 | 0.332 |
R-HSA-168256 | Immune System | 4.692651e-01 | 0.329 |
R-HSA-1474244 | Extracellular matrix organization | 4.705537e-01 | 0.327 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 4.733070e-01 | 0.325 |
R-HSA-977225 | Amyloid fiber formation | 4.771409e-01 | 0.321 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 4.782656e-01 | 0.320 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 4.806230e-01 | 0.318 |
R-HSA-5357801 | Programmed Cell Death | 4.876567e-01 | 0.312 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 4.884775e-01 | 0.311 |
R-HSA-6802957 | Oncogenic MAPK signaling | 4.922019e-01 | 0.308 |
R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs | 4.958995e-01 | 0.305 |
R-HSA-70268 | Pyruvate metabolism | 5.032146e-01 | 0.298 |
R-HSA-447115 | Interleukin-12 family signaling | 5.032146e-01 | 0.298 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 5.038386e-01 | 0.298 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 5.068327e-01 | 0.295 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 5.139905e-01 | 0.289 |
R-HSA-381070 | IRE1alpha activates chaperones | 5.210454e-01 | 0.283 |
R-HSA-168249 | Innate Immune System | 5.224475e-01 | 0.282 |
R-HSA-8951664 | Neddylation | 5.241593e-01 | 0.281 |
R-HSA-391251 | Protein folding | 5.245346e-01 | 0.280 |
R-HSA-174824 | Plasma lipoprotein assembly, remodeling, and clearance | 5.245346e-01 | 0.280 |
R-HSA-2682334 | EPH-Ephrin signaling | 5.245346e-01 | 0.280 |
R-HSA-68867 | Assembly of the pre-replicative complex | 5.279987e-01 | 0.277 |
R-HSA-162906 | HIV Infection | 5.373967e-01 | 0.270 |
R-HSA-6807878 | COPI-mediated anterograde transport | 5.416065e-01 | 0.266 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 5.416065e-01 | 0.266 |
R-HSA-8957275 | Post-translational protein phosphorylation | 5.482637e-01 | 0.261 |
R-HSA-190236 | Signaling by FGFR | 5.482637e-01 | 0.261 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 5.486751e-01 | 0.261 |
R-HSA-382556 | ABC-family proteins mediated transport | 5.548252e-01 | 0.256 |
R-HSA-15869 | Metabolism of nucleotides | 5.567794e-01 | 0.254 |
R-HSA-1266738 | Developmental Biology | 5.757435e-01 | 0.240 |
R-HSA-69239 | Synthesis of DNA | 5.801392e-01 | 0.236 |
R-HSA-4839726 | Chromatin organization | 5.837589e-01 | 0.234 |
R-HSA-9609646 | HCMV Infection | 5.857841e-01 | 0.232 |
R-HSA-69002 | DNA Replication Pre-Initiation | 5.862414e-01 | 0.232 |
R-HSA-6803157 | Antimicrobial peptides | 5.922557e-01 | 0.227 |
R-HSA-5688426 | Deubiquitination | 5.958017e-01 | 0.225 |
R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l... | 6.040254e-01 | 0.219 |
R-HSA-418594 | G alpha (i) signalling events | 6.041661e-01 | 0.219 |
R-HSA-9007101 | Rab regulation of trafficking | 6.154582e-01 | 0.211 |
R-HSA-2980736 | Peptide hormone metabolism | 6.154582e-01 | 0.211 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 6.319966e-01 | 0.199 |
R-HSA-2132295 | MHC class II antigen presentation | 6.319966e-01 | 0.199 |
R-HSA-446728 | Cell junction organization | 6.395652e-01 | 0.194 |
R-HSA-69206 | G1/S Transition | 6.399993e-01 | 0.194 |
R-HSA-114608 | Platelet degranulation | 6.452384e-01 | 0.190 |
R-HSA-69481 | G2/M Checkpoints | 6.452384e-01 | 0.190 |
R-HSA-5576891 | Cardiac conduction | 6.580076e-01 | 0.182 |
R-HSA-5673001 | RAF/MAP kinase cascade | 6.591579e-01 | 0.181 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 6.605062e-01 | 0.180 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 6.629867e-01 | 0.178 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 6.711814e-01 | 0.173 |
R-HSA-195721 | Signaling by WNT | 6.745537e-01 | 0.171 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 6.751224e-01 | 0.171 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 6.755246e-01 | 0.170 |
R-HSA-5358351 | Signaling by Hedgehog | 6.774970e-01 | 0.169 |
R-HSA-597592 | Post-translational protein modification | 6.864252e-01 | 0.163 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 6.913876e-01 | 0.160 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 6.981088e-01 | 0.156 |
R-HSA-69242 | S Phase | 7.025087e-01 | 0.153 |
R-HSA-1500931 | Cell-Cell communication | 7.036649e-01 | 0.153 |
R-HSA-69306 | DNA Replication | 7.132324e-01 | 0.147 |
R-HSA-9609507 | Protein localization | 7.132324e-01 | 0.147 |
R-HSA-9006936 | Signaling by TGFB family members | 7.276046e-01 | 0.138 |
R-HSA-9824446 | Viral Infection Pathways | 7.361501e-01 | 0.133 |
R-HSA-382551 | Transport of small molecules | 7.422432e-01 | 0.129 |
R-HSA-5683057 | MAPK family signaling cascades | 7.487520e-01 | 0.126 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 7.696555e-01 | 0.114 |
R-HSA-69275 | G2/M Transition | 7.766547e-01 | 0.110 |
R-HSA-453274 | Mitotic G2-G2/M phases | 7.799182e-01 | 0.108 |
R-HSA-5617833 | Cilium Assembly | 7.831344e-01 | 0.106 |
R-HSA-1630316 | Glycosaminoglycan metabolism | 7.878716e-01 | 0.104 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 7.894277e-01 | 0.103 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 7.948039e-01 | 0.100 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 7.985297e-01 | 0.098 |
R-HSA-162582 | Signal Transduction | 8.039818e-01 | 0.095 |
R-HSA-72172 | mRNA Splicing | 8.058159e-01 | 0.094 |
R-HSA-397014 | Muscle contraction | 8.169341e-01 | 0.088 |
R-HSA-8978868 | Fatty acid metabolism | 8.205748e-01 | 0.086 |
R-HSA-388396 | GPCR downstream signalling | 8.346288e-01 | 0.079 |
R-HSA-446203 | Asparagine N-linked glycosylation | 8.351857e-01 | 0.078 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 8.396954e-01 | 0.076 |
R-HSA-5668914 | Diseases of metabolism | 8.398143e-01 | 0.076 |
R-HSA-72766 | Translation | 8.416329e-01 | 0.075 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 8.435514e-01 | 0.074 |
R-HSA-3247509 | Chromatin modifying enzymes | 8.443592e-01 | 0.073 |
R-HSA-449147 | Signaling by Interleukins | 8.525729e-01 | 0.069 |
R-HSA-392499 | Metabolism of proteins | 8.598977e-01 | 0.066 |
R-HSA-421270 | Cell-cell junction organization | 8.627249e-01 | 0.064 |
R-HSA-9711123 | Cellular response to chemical stress | 8.789399e-01 | 0.056 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 8.841970e-01 | 0.053 |
R-HSA-372790 | Signaling by GPCR | 8.864196e-01 | 0.052 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 8.908559e-01 | 0.050 |
R-HSA-1280218 | Adaptive Immune System | 8.934594e-01 | 0.049 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 9.176519e-01 | 0.037 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 9.295446e-01 | 0.032 |
R-HSA-109582 | Hemostasis | 9.356944e-01 | 0.029 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 9.406227e-01 | 0.027 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 9.488818e-01 | 0.023 |
R-HSA-5663205 | Infectious disease | 9.710615e-01 | 0.013 |
R-HSA-1643685 | Disease | 9.818068e-01 | 0.008 |
R-HSA-556833 | Metabolism of lipids | 9.991429e-01 | 0.000 |
R-HSA-74160 | Gene expression (Transcription) | 9.992439e-01 | 0.000 |
R-HSA-212436 | Generic Transcription Pathway | 9.999182e-01 | 0.000 |
R-HSA-73857 | RNA Polymerase II Transcription | 9.999717e-01 | 0.000 |
R-HSA-1430728 | Metabolism | 9.999740e-01 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
CLK3 |
0.806 | 0.357 | 1 | 0.778 |
CDK8 |
0.804 | 0.535 | 1 | 0.890 |
CDK18 |
0.804 | 0.558 | 1 | 0.900 |
CDK19 |
0.802 | 0.526 | 1 | 0.896 |
CDK17 |
0.801 | 0.565 | 1 | 0.904 |
KIS |
0.799 | 0.473 | 1 | 0.887 |
CDK13 |
0.799 | 0.546 | 1 | 0.901 |
JNK2 |
0.799 | 0.578 | 1 | 0.915 |
P38G |
0.798 | 0.566 | 1 | 0.909 |
CDK5 |
0.796 | 0.533 | 1 | 0.887 |
CDK12 |
0.796 | 0.546 | 1 | 0.905 |
CDK1 |
0.796 | 0.527 | 1 | 0.914 |
DYRK2 |
0.796 | 0.483 | 1 | 0.858 |
HIPK2 |
0.794 | 0.478 | 1 | 0.873 |
CDK7 |
0.794 | 0.502 | 1 | 0.899 |
CLK2 |
0.794 | 0.324 | -3 | 0.567 |
CDK9 |
0.794 | 0.533 | 1 | 0.902 |
CDK16 |
0.791 | 0.540 | 1 | 0.899 |
CDK3 |
0.791 | 0.478 | 1 | 0.906 |
JNK3 |
0.791 | 0.557 | 1 | 0.905 |
CLK1 |
0.791 | 0.299 | -3 | 0.579 |
DYRK4 |
0.791 | 0.502 | 1 | 0.894 |
MTOR |
0.790 | 0.318 | 1 | 0.619 |
NLK |
0.789 | 0.468 | 1 | 0.790 |
SRPK1 |
0.789 | 0.222 | -3 | 0.554 |
ERK1 |
0.789 | 0.518 | 1 | 0.894 |
CDK14 |
0.787 | 0.539 | 1 | 0.895 |
CDK10 |
0.787 | 0.504 | 1 | 0.897 |
CLK4 |
0.786 | 0.272 | -3 | 0.580 |
P38B |
0.786 | 0.525 | 1 | 0.893 |
DYRK1B |
0.785 | 0.472 | 1 | 0.880 |
HIPK1 |
0.785 | 0.441 | 1 | 0.853 |
HIPK4 |
0.785 | 0.285 | 1 | 0.744 |
P38A |
0.783 | 0.510 | 1 | 0.869 |
P38D |
0.782 | 0.537 | 1 | 0.888 |
SRPK2 |
0.781 | 0.170 | -3 | 0.495 |
ERK2 |
0.779 | 0.502 | 1 | 0.888 |
CDK2 |
0.779 | 0.402 | 1 | 0.873 |
COT |
0.778 | -0.020 | 2 | 0.890 |
ERK5 |
0.777 | 0.238 | 1 | 0.703 |
DYRK1A |
0.775 | 0.363 | 1 | 0.860 |
HIPK3 |
0.775 | 0.416 | 1 | 0.830 |
DYRK3 |
0.775 | 0.357 | 1 | 0.821 |
CDK6 |
0.773 | 0.506 | 1 | 0.890 |
MST4 |
0.772 | 0.095 | 2 | 0.858 |
JNK1 |
0.772 | 0.497 | 1 | 0.913 |
NUAK2 |
0.771 | 0.059 | -3 | 0.640 |
CDK4 |
0.771 | 0.511 | 1 | 0.904 |
MARK4 |
0.771 | 0.107 | 4 | 0.838 |
CDC7 |
0.770 | -0.031 | 1 | 0.531 |
CDKL1 |
0.770 | 0.092 | -3 | 0.590 |
ICK |
0.770 | 0.205 | -3 | 0.615 |
NDR2 |
0.770 | 0.008 | -3 | 0.629 |
WNK1 |
0.770 | 0.040 | -2 | 0.879 |
SRPK3 |
0.769 | 0.147 | -3 | 0.521 |
CDKL5 |
0.768 | 0.085 | -3 | 0.588 |
SKMLCK |
0.768 | 0.027 | -2 | 0.868 |
PRPK |
0.767 | -0.047 | -1 | 0.656 |
GCN2 |
0.766 | -0.085 | 2 | 0.824 |
CAMK1B |
0.765 | -0.007 | -3 | 0.659 |
DSTYK |
0.764 | -0.066 | 2 | 0.916 |
RSK2 |
0.764 | 0.007 | -3 | 0.584 |
PIM3 |
0.764 | -0.050 | -3 | 0.621 |
PRP4 |
0.764 | 0.281 | -3 | 0.558 |
PKN3 |
0.764 | -0.015 | -3 | 0.627 |
NIM1 |
0.764 | 0.116 | 3 | 0.733 |
PKCD |
0.764 | 0.044 | 2 | 0.806 |
PKN2 |
0.763 | 0.004 | -3 | 0.659 |
NDR1 |
0.763 | -0.016 | -3 | 0.639 |
QSK |
0.762 | 0.088 | 4 | 0.819 |
RAF1 |
0.762 | -0.117 | 1 | 0.512 |
ULK2 |
0.761 | -0.109 | 2 | 0.796 |
MOS |
0.760 | -0.068 | 1 | 0.554 |
PDHK4 |
0.760 | -0.125 | 1 | 0.557 |
NEK6 |
0.760 | -0.036 | -2 | 0.839 |
BMPR2 |
0.760 | -0.118 | -2 | 0.854 |
TBK1 |
0.760 | -0.136 | 1 | 0.440 |
HUNK |
0.760 | -0.059 | 2 | 0.839 |
TGFBR2 |
0.759 | -0.039 | -2 | 0.795 |
NIK |
0.759 | -0.018 | -3 | 0.676 |
P90RSK |
0.759 | -0.014 | -3 | 0.569 |
RSK3 |
0.759 | -0.011 | -3 | 0.577 |
PRKD1 |
0.759 | -0.034 | -3 | 0.620 |
AMPKA1 |
0.759 | -0.009 | -3 | 0.662 |
QIK |
0.758 | 0.054 | -3 | 0.648 |
SIK |
0.758 | 0.054 | -3 | 0.591 |
TSSK1 |
0.758 | 0.012 | -3 | 0.674 |
PKACG |
0.758 | 0.001 | -2 | 0.759 |
PRKD2 |
0.758 | -0.023 | -3 | 0.598 |
MAK |
0.757 | 0.305 | -2 | 0.686 |
MARK3 |
0.757 | 0.078 | 4 | 0.780 |
IKKB |
0.757 | -0.153 | -2 | 0.725 |
SGK3 |
0.757 | 0.049 | -3 | 0.612 |
MNK2 |
0.756 | 0.021 | -2 | 0.805 |
AURC |
0.756 | 0.033 | -2 | 0.691 |
PIM1 |
0.756 | -0.008 | -3 | 0.587 |
CAMLCK |
0.756 | -0.002 | -2 | 0.843 |
DAPK2 |
0.755 | -0.008 | -3 | 0.657 |
PDHK1 |
0.755 | -0.125 | 1 | 0.530 |
PKCG |
0.755 | 0.029 | 2 | 0.773 |
ATR |
0.755 | -0.061 | 1 | 0.518 |
CAMK2G |
0.755 | -0.083 | 2 | 0.823 |
AMPKA2 |
0.755 | -0.011 | -3 | 0.640 |
IKKE |
0.755 | -0.153 | 1 | 0.437 |
NEK7 |
0.755 | -0.119 | -3 | 0.591 |
PKCB |
0.754 | 0.023 | 2 | 0.775 |
GRK5 |
0.754 | -0.098 | -3 | 0.657 |
CAMK2D |
0.754 | -0.051 | -3 | 0.650 |
LATS2 |
0.754 | -0.044 | -5 | 0.769 |
PKCA |
0.754 | 0.050 | 2 | 0.756 |
BMPR1B |
0.754 | 0.033 | 1 | 0.527 |
MAPKAPK3 |
0.753 | -0.069 | -3 | 0.609 |
P70S6KB |
0.753 | -0.028 | -3 | 0.616 |
WNK3 |
0.753 | -0.142 | 1 | 0.483 |
MNK1 |
0.753 | 0.023 | -2 | 0.808 |
MARK2 |
0.753 | 0.072 | 4 | 0.762 |
NUAK1 |
0.752 | -0.021 | -3 | 0.616 |
PKACB |
0.751 | 0.034 | -2 | 0.701 |
TSSK2 |
0.751 | -0.038 | -5 | 0.848 |
CHAK2 |
0.751 | -0.076 | -1 | 0.666 |
RIPK3 |
0.751 | -0.136 | 3 | 0.743 |
IRE1 |
0.750 | -0.057 | 1 | 0.456 |
TGFBR1 |
0.750 | 0.030 | -2 | 0.808 |
RSK4 |
0.749 | -0.001 | -3 | 0.541 |
BCKDK |
0.749 | -0.108 | -1 | 0.602 |
IKKA |
0.749 | -0.095 | -2 | 0.706 |
MLK1 |
0.749 | -0.131 | 2 | 0.844 |
ULK1 |
0.749 | -0.157 | -3 | 0.592 |
PKCH |
0.749 | 0.003 | 2 | 0.754 |
PAK6 |
0.748 | 0.033 | -2 | 0.706 |
ALK4 |
0.748 | 0.002 | -2 | 0.833 |
AKT2 |
0.748 | 0.018 | -3 | 0.527 |
MAPKAPK2 |
0.748 | -0.050 | -3 | 0.563 |
MOK |
0.748 | 0.271 | 1 | 0.764 |
PRKX |
0.748 | 0.041 | -3 | 0.531 |
PKCZ |
0.748 | -0.005 | 2 | 0.806 |
BRSK1 |
0.747 | -0.024 | -3 | 0.615 |
MARK1 |
0.747 | 0.040 | 4 | 0.795 |
ERK7 |
0.747 | 0.204 | 2 | 0.619 |
LATS1 |
0.747 | -0.002 | -3 | 0.636 |
MSK2 |
0.747 | -0.042 | -3 | 0.540 |
MASTL |
0.746 | -0.131 | -2 | 0.797 |
BRSK2 |
0.746 | -0.030 | -3 | 0.648 |
DNAPK |
0.746 | 0.017 | 1 | 0.439 |
NEK9 |
0.746 | -0.147 | 2 | 0.851 |
PAK1 |
0.746 | -0.033 | -2 | 0.773 |
GRK1 |
0.746 | -0.059 | -2 | 0.769 |
PRKD3 |
0.745 | -0.044 | -3 | 0.575 |
MELK |
0.745 | -0.075 | -3 | 0.639 |
PHKG1 |
0.745 | -0.065 | -3 | 0.633 |
NEK2 |
0.745 | -0.065 | 2 | 0.834 |
CAMK4 |
0.745 | -0.095 | -3 | 0.637 |
DCAMKL1 |
0.744 | 0.005 | -3 | 0.613 |
ANKRD3 |
0.744 | -0.131 | 1 | 0.513 |
ATM |
0.744 | -0.065 | 1 | 0.462 |
CAMK2B |
0.743 | -0.045 | 2 | 0.798 |
PAK3 |
0.743 | -0.062 | -2 | 0.770 |
MSK1 |
0.743 | -0.018 | -3 | 0.566 |
IRE2 |
0.743 | -0.066 | 2 | 0.750 |
GRK7 |
0.743 | 0.006 | 1 | 0.528 |
PKG2 |
0.743 | -0.005 | -2 | 0.701 |
AURB |
0.743 | 0.005 | -2 | 0.685 |
RIPK1 |
0.742 | -0.167 | 1 | 0.474 |
MLK2 |
0.742 | -0.133 | 2 | 0.833 |
CAMK2A |
0.742 | -0.048 | 2 | 0.822 |
MLK3 |
0.742 | -0.068 | 2 | 0.779 |
PKR |
0.742 | -0.046 | 1 | 0.505 |
MEK1 |
0.742 | -0.035 | 2 | 0.861 |
GRK6 |
0.741 | -0.140 | 1 | 0.538 |
MYLK4 |
0.741 | -0.029 | -2 | 0.783 |
PLK4 |
0.740 | -0.024 | 2 | 0.645 |
PKACA |
0.740 | 0.020 | -2 | 0.661 |
FAM20C |
0.740 | 0.006 | 2 | 0.648 |
PKCT |
0.740 | -0.001 | 2 | 0.755 |
AKT1 |
0.740 | 0.015 | -3 | 0.552 |
TTBK2 |
0.740 | -0.172 | 2 | 0.742 |
WNK4 |
0.739 | -0.022 | -2 | 0.868 |
MPSK1 |
0.739 | 0.112 | 1 | 0.480 |
DRAK1 |
0.739 | -0.058 | 1 | 0.501 |
PKCI |
0.739 | 0.029 | 2 | 0.781 |
PINK1 |
0.739 | 0.044 | 1 | 0.622 |
MST3 |
0.739 | 0.041 | 2 | 0.866 |
VRK2 |
0.739 | -0.017 | 1 | 0.581 |
ACVR2A |
0.738 | -0.041 | -2 | 0.782 |
DLK |
0.738 | -0.234 | 1 | 0.530 |
ACVR2B |
0.738 | -0.044 | -2 | 0.787 |
PIM2 |
0.737 | -0.015 | -3 | 0.580 |
YSK4 |
0.737 | -0.118 | 1 | 0.467 |
CHK1 |
0.737 | -0.058 | -3 | 0.644 |
GRK4 |
0.737 | -0.170 | -2 | 0.803 |
TAO3 |
0.737 | 0.044 | 1 | 0.515 |
AURA |
0.736 | 0.001 | -2 | 0.663 |
ALK2 |
0.736 | -0.032 | -2 | 0.806 |
CAMK1G |
0.736 | -0.055 | -3 | 0.581 |
BMPR1A |
0.736 | 0.008 | 1 | 0.511 |
PLK1 |
0.736 | -0.132 | -2 | 0.766 |
GSK3A |
0.736 | 0.119 | 4 | 0.451 |
SMMLCK |
0.735 | -0.009 | -3 | 0.627 |
PKCE |
0.735 | 0.033 | 2 | 0.755 |
PHKG2 |
0.735 | -0.045 | -3 | 0.642 |
DCAMKL2 |
0.734 | -0.026 | -3 | 0.632 |
PAK2 |
0.734 | -0.073 | -2 | 0.760 |
CHAK1 |
0.733 | -0.146 | 2 | 0.773 |
SSTK |
0.732 | -0.027 | 4 | 0.806 |
MEKK3 |
0.732 | -0.086 | 1 | 0.500 |
SGK1 |
0.732 | 0.033 | -3 | 0.467 |
ZAK |
0.732 | -0.086 | 1 | 0.480 |
PERK |
0.731 | -0.105 | -2 | 0.821 |
MLK4 |
0.731 | -0.126 | 2 | 0.768 |
SMG1 |
0.731 | -0.106 | 1 | 0.472 |
MEKK2 |
0.730 | -0.052 | 2 | 0.820 |
MEK5 |
0.730 | -0.117 | 2 | 0.841 |
GRK2 |
0.730 | -0.073 | -2 | 0.699 |
MEKK1 |
0.730 | -0.092 | 1 | 0.485 |
PKN1 |
0.730 | -0.021 | -3 | 0.572 |
MAPKAPK5 |
0.730 | -0.132 | -3 | 0.541 |
BRAF |
0.729 | -0.099 | -4 | 0.698 |
SNRK |
0.729 | -0.156 | 2 | 0.687 |
TLK2 |
0.729 | -0.124 | 1 | 0.453 |
AKT3 |
0.729 | 0.008 | -3 | 0.474 |
PAK5 |
0.728 | -0.017 | -2 | 0.642 |
P70S6K |
0.728 | -0.060 | -3 | 0.551 |
HRI |
0.728 | -0.152 | -2 | 0.824 |
CAMK1D |
0.727 | -0.049 | -3 | 0.542 |
IRAK4 |
0.727 | -0.111 | 1 | 0.449 |
CK1E |
0.726 | -0.064 | -3 | 0.313 |
GAK |
0.726 | 0.002 | 1 | 0.529 |
NEK5 |
0.726 | -0.131 | 1 | 0.476 |
TAO2 |
0.726 | -0.008 | 2 | 0.854 |
PLK3 |
0.726 | -0.143 | 2 | 0.800 |
GSK3B |
0.725 | 0.023 | 4 | 0.444 |
PDK1 |
0.724 | -0.025 | 1 | 0.500 |
PAK4 |
0.724 | -0.011 | -2 | 0.653 |
SBK |
0.724 | 0.041 | -3 | 0.447 |
TNIK |
0.723 | 0.025 | 3 | 0.795 |
DAPK3 |
0.723 | -0.022 | -3 | 0.608 |
HPK1 |
0.723 | 0.014 | 1 | 0.505 |
MRCKB |
0.723 | 0.004 | -3 | 0.588 |
GCK |
0.722 | -0.012 | 1 | 0.512 |
MEKK6 |
0.722 | 0.007 | 1 | 0.485 |
NEK11 |
0.722 | -0.084 | 1 | 0.505 |
TLK1 |
0.721 | -0.146 | -2 | 0.810 |
MAP3K15 |
0.721 | 0.005 | 1 | 0.473 |
MINK |
0.721 | -0.003 | 1 | 0.474 |
KHS2 |
0.720 | 0.055 | 1 | 0.503 |
ROCK2 |
0.720 | 0.012 | -3 | 0.618 |
PASK |
0.720 | -0.081 | -3 | 0.612 |
KHS1 |
0.720 | 0.032 | 1 | 0.480 |
HGK |
0.720 | -0.015 | 3 | 0.799 |
CHK2 |
0.719 | -0.045 | -3 | 0.502 |
CK1G1 |
0.719 | -0.083 | -3 | 0.327 |
CK1D |
0.718 | -0.059 | -3 | 0.284 |
NEK8 |
0.718 | -0.145 | 2 | 0.833 |
MRCKA |
0.718 | -0.012 | -3 | 0.599 |
LRRK2 |
0.718 | -0.008 | 2 | 0.863 |
HASPIN |
0.718 | 0.019 | -1 | 0.585 |
NEK4 |
0.717 | -0.101 | 1 | 0.461 |
DAPK1 |
0.717 | -0.028 | -3 | 0.583 |
CAMK1A |
0.717 | -0.043 | -3 | 0.519 |
IRAK1 |
0.717 | -0.197 | -1 | 0.563 |
TTBK1 |
0.716 | -0.158 | 2 | 0.653 |
LKB1 |
0.716 | -0.104 | -3 | 0.615 |
YSK1 |
0.716 | 0.011 | 2 | 0.826 |
LOK |
0.716 | -0.064 | -2 | 0.764 |
GRK3 |
0.715 | -0.080 | -2 | 0.664 |
MST2 |
0.715 | -0.085 | 1 | 0.495 |
DMPK1 |
0.714 | 0.029 | -3 | 0.606 |
EEF2K |
0.714 | -0.043 | 3 | 0.763 |
CAMKK2 |
0.713 | -0.136 | -2 | 0.715 |
NEK1 |
0.713 | -0.087 | 1 | 0.462 |
CAMKK1 |
0.713 | -0.166 | -2 | 0.704 |
CK1A2 |
0.713 | -0.077 | -3 | 0.282 |
PDHK3_TYR |
0.713 | 0.088 | 4 | 0.856 |
PBK |
0.712 | -0.022 | 1 | 0.461 |
CK2A2 |
0.712 | -0.055 | 1 | 0.459 |
PKMYT1_TYR |
0.712 | 0.196 | 3 | 0.791 |
SLK |
0.712 | -0.073 | -2 | 0.712 |
PKG1 |
0.711 | -0.030 | -2 | 0.632 |
MST1 |
0.710 | -0.095 | 1 | 0.479 |
MEK2 |
0.708 | -0.090 | 2 | 0.821 |
ROCK1 |
0.708 | -0.003 | -3 | 0.599 |
TAK1 |
0.707 | -0.129 | 1 | 0.485 |
VRK1 |
0.707 | -0.117 | 2 | 0.838 |
LIMK2_TYR |
0.707 | 0.060 | -3 | 0.698 |
NEK3 |
0.706 | -0.071 | 1 | 0.452 |
STK33 |
0.706 | -0.130 | 2 | 0.639 |
MAP2K4_TYR |
0.705 | 0.018 | -1 | 0.674 |
TESK1_TYR |
0.705 | -0.032 | 3 | 0.802 |
BUB1 |
0.704 | -0.040 | -5 | 0.768 |
CK2A1 |
0.703 | -0.061 | 1 | 0.452 |
BMPR2_TYR |
0.703 | 0.016 | -1 | 0.623 |
MAP2K7_TYR |
0.703 | -0.055 | 2 | 0.863 |
PDHK4_TYR |
0.702 | -0.016 | 2 | 0.882 |
RIPK2 |
0.702 | -0.199 | 1 | 0.437 |
MAP2K6_TYR |
0.702 | -0.005 | -1 | 0.666 |
CRIK |
0.701 | -0.018 | -3 | 0.548 |
TAO1 |
0.701 | -0.034 | 1 | 0.444 |
MYO3B |
0.700 | -0.006 | 2 | 0.835 |
BIKE |
0.699 | -0.017 | 1 | 0.447 |
LIMK1_TYR |
0.699 | -0.011 | 2 | 0.849 |
PINK1_TYR |
0.698 | -0.114 | 1 | 0.543 |
PDHK1_TYR |
0.697 | -0.082 | -1 | 0.652 |
MYO3A |
0.697 | -0.020 | 1 | 0.475 |
OSR1 |
0.696 | -0.080 | 2 | 0.819 |
PLK2 |
0.696 | -0.121 | -3 | 0.508 |
ASK1 |
0.695 | -0.076 | 1 | 0.467 |
TNNI3K_TYR |
0.694 | 0.012 | 1 | 0.505 |
TTK |
0.694 | -0.097 | -2 | 0.797 |
TYK2 |
0.692 | -0.136 | 1 | 0.485 |
AAK1 |
0.692 | 0.019 | 1 | 0.398 |
MST1R |
0.692 | -0.126 | 3 | 0.789 |
JAK2 |
0.691 | -0.103 | 1 | 0.506 |
ROS1 |
0.690 | -0.124 | 3 | 0.756 |
RET |
0.690 | -0.199 | 1 | 0.501 |
CSF1R |
0.690 | -0.114 | 3 | 0.778 |
DDR1 |
0.688 | -0.135 | 4 | 0.776 |
JAK1 |
0.688 | -0.030 | 1 | 0.456 |
TNK1 |
0.686 | -0.073 | 3 | 0.748 |
TYRO3 |
0.686 | -0.194 | 3 | 0.770 |
EPHA6 |
0.685 | -0.128 | -1 | 0.537 |
ABL2 |
0.685 | -0.119 | -1 | 0.556 |
TXK |
0.684 | -0.081 | 1 | 0.534 |
TNK2 |
0.683 | -0.116 | 3 | 0.742 |
NEK10_TYR |
0.683 | -0.101 | 1 | 0.417 |
CK1A |
0.683 | -0.085 | -3 | 0.210 |
JAK3 |
0.682 | -0.169 | 1 | 0.485 |
YES1 |
0.681 | -0.137 | -1 | 0.571 |
ABL1 |
0.681 | -0.127 | -1 | 0.554 |
INSRR |
0.681 | -0.154 | 3 | 0.723 |
FGR |
0.680 | -0.181 | 1 | 0.509 |
FGFR2 |
0.680 | -0.131 | 3 | 0.746 |
FGFR1 |
0.680 | -0.103 | 3 | 0.742 |
KDR |
0.680 | -0.129 | 3 | 0.745 |
EPHB4 |
0.679 | -0.187 | -1 | 0.523 |
TEK |
0.679 | -0.092 | 3 | 0.698 |
PDGFRB |
0.679 | -0.192 | 3 | 0.786 |
ITK |
0.679 | -0.137 | -1 | 0.508 |
WEE1_TYR |
0.679 | -0.074 | -1 | 0.539 |
KIT |
0.678 | -0.151 | 3 | 0.768 |
EPHA4 |
0.678 | -0.100 | 2 | 0.796 |
SRMS |
0.678 | -0.160 | 1 | 0.520 |
FLT3 |
0.677 | -0.170 | 3 | 0.763 |
FER |
0.677 | -0.209 | 1 | 0.531 |
YANK3 |
0.676 | -0.082 | 2 | 0.429 |
AXL |
0.676 | -0.177 | 3 | 0.756 |
ALPHAK3 |
0.676 | -0.141 | -1 | 0.562 |
HCK |
0.675 | -0.171 | -1 | 0.517 |
BLK |
0.675 | -0.099 | -1 | 0.525 |
LCK |
0.675 | -0.133 | -1 | 0.514 |
DDR2 |
0.674 | -0.070 | 3 | 0.719 |
EPHB1 |
0.674 | -0.184 | 1 | 0.514 |
STLK3 |
0.673 | -0.182 | 1 | 0.453 |
MERTK |
0.673 | -0.168 | 3 | 0.742 |
TEC |
0.673 | -0.148 | -1 | 0.460 |
MET |
0.672 | -0.156 | 3 | 0.762 |
PDGFRA |
0.672 | -0.208 | 3 | 0.790 |
BMX |
0.672 | -0.125 | -1 | 0.437 |
EPHB3 |
0.670 | -0.195 | -1 | 0.493 |
FGFR3 |
0.670 | -0.135 | 3 | 0.724 |
EPHB2 |
0.669 | -0.178 | -1 | 0.492 |
FLT1 |
0.668 | -0.173 | -1 | 0.548 |
BTK |
0.668 | -0.220 | -1 | 0.486 |
ALK |
0.667 | -0.191 | 3 | 0.715 |
NTRK1 |
0.667 | -0.208 | -1 | 0.550 |
FLT4 |
0.667 | -0.174 | 3 | 0.724 |
MATK |
0.667 | -0.121 | -1 | 0.534 |
ERBB2 |
0.666 | -0.177 | 1 | 0.487 |
PTK2B |
0.666 | -0.119 | -1 | 0.507 |
NTRK2 |
0.666 | -0.213 | 3 | 0.752 |
FYN |
0.665 | -0.124 | -1 | 0.487 |
EPHA7 |
0.665 | -0.151 | 2 | 0.798 |
NTRK3 |
0.665 | -0.159 | -1 | 0.509 |
LTK |
0.665 | -0.195 | 3 | 0.725 |
INSR |
0.664 | -0.181 | 3 | 0.705 |
FRK |
0.664 | -0.170 | -1 | 0.526 |
EGFR |
0.663 | -0.114 | 1 | 0.441 |
EPHA1 |
0.662 | -0.192 | 3 | 0.746 |
EPHA3 |
0.662 | -0.166 | 2 | 0.766 |
PTK6 |
0.661 | -0.240 | -1 | 0.486 |
LYN |
0.661 | -0.168 | 3 | 0.707 |
PTK2 |
0.659 | -0.077 | -1 | 0.461 |
SRC |
0.658 | -0.151 | -1 | 0.504 |
FGFR4 |
0.658 | -0.129 | -1 | 0.512 |
CSK |
0.657 | -0.173 | 2 | 0.796 |
EPHA8 |
0.656 | -0.149 | -1 | 0.473 |
MUSK |
0.656 | -0.135 | 1 | 0.404 |
EPHA5 |
0.655 | -0.168 | 2 | 0.782 |
CK1G3 |
0.655 | -0.115 | -3 | 0.176 |
SYK |
0.654 | -0.111 | -1 | 0.461 |
EPHA2 |
0.651 | -0.136 | -1 | 0.436 |
ERBB4 |
0.649 | -0.111 | 1 | 0.458 |
IGF1R |
0.648 | -0.171 | 3 | 0.639 |
YANK2 |
0.643 | -0.106 | 2 | 0.443 |
FES |
0.642 | -0.138 | -1 | 0.431 |
ZAP70 |
0.639 | -0.098 | -1 | 0.440 |
CK1G2 |
0.633 | -0.116 | -3 | 0.255 |